| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.631 | 0.004 | 0.857 | Non-steroidal antiinflammatory agent | 0.624 0.004 DBMET01274 0.857 0.003 DBMET01279 0.582 0.005 DBMET01280 0.664 0.004 DBMET01275 0.575 0.005 DBMET01284 0.791 0.003 DBMET01281 0.144 0.123 DBMET01276 0.609 0.004 DBMET01285 0.23 0.052 DBMET01283 0.412 0.012 DBMET01286 | DBMET01279 | |
| 0.629 | 0.003 | 0.629 | Interleukin 8 antagonist | 0.42 0.004 DBMET01274 0.159 0.029 DBMET01279 0.42 0.004 DBMET01280 0.574 0.003 DBMET01275 0.275 0.005 DBMET01284 0.106 0.083 DBMET01281 0.375 0.004 DBMET01285 0.155 0.031 DBMET01286 | ||
| 0.634 | 0.044 | 0.81 | Antiinflammatory | 0.676 0.035 DBMET01274 0.8 0.015 DBMET01279 0.674 0.036 DBMET01280 0.664 0.038 DBMET01275 0.707 0.029 DBMET01284 0.81 0.014 DBMET01281 0.31 0.206 DBMET01282 0.28 0.235 DBMET01276 0.698 0.031 DBMET01285 0.699 0.031 DBMET01283 0.378 0.153 DBMET01287 0.696 0.032 DBMET01286 0.431 0.12 DBMET01288 | DBMET01281 | |
| 0.528 | 0.042 | 0.564 | Analgesic | 0.504 0.048 DBMET01274 0.297 0.144 DBMET01279 0.552 0.036 DBMET01280 0.542 0.038 DBMET01275 0.529 0.041 DBMET01284 0.329 0.121 DBMET01281 0.276 0.161 DBMET01282 0.223 0.21 DBMET01276 0.564 0.034 DBMET01285 0.269 0.166 DBMET01287 0.308 0.136 DBMET01286 | DBMET01285 | |
| 0.403 | 0.007 | 0.403 | Cyclooxygenase inhibitor | 0.384 0.008 DBMET01274 0.32 0.015 DBMET01279 0.384 0.008 DBMET01280 0.391 0.008 DBMET01275 0.366 0.009 DBMET01284 0.311 0.016 DBMET01281 0.129 0.088 DBMET01282 0.121 0.097 DBMET01276 0.372 0.009 DBMET01285 0.12 0.1 DBMET01287 0.324 0.014 DBMET01286 | ||
| 0.382 | 0.008 | 0.382 | Cyclooxygenase 1 inhibitor | 0.364 0.009 DBMET01274 0.281 0.017 DBMET01279 0.382 0.008 DBMET01280 0.376 0.008 DBMET01275 0.364 0.009 DBMET01284 0.285 0.016 DBMET01281 0.149 0.057 DBMET01282 0.13 0.07 DBMET01276 0.376 0.008 DBMET01285 0.116 0.085 DBMET01283 0.145 0.059 DBMET01287 0.343 0.01 DBMET01286 0.144 0.06 DBMET01288 | ||
| 0.428 | 0.076 | 0.688 | Cyclophilin D inhibitor | 0.518 0.045 DBMET01274 0.64 0.021 DBMET01279 0.47 0.06 DBMET01280 0.507 0.048 DBMET01275 0.552 0.037 DBMET01284 0.657 0.019 DBMET01281 0.295 0.167 DBMET01276 0.542 0.039 DBMET01285 0.688 0.015 DBMET01283 0.352 0.12 DBMET01287 0.554 0.037 DBMET01286 0.394 0.094 DBMET01288 | DBMET01283 | |
| 0.312 | 0.004 | 0.334 | Prostaglandin-E synthase inhibitor | 0.28 0.004 DBMET01274 0.211 0.005 DBMET01280 0.334 0.004 DBMET01275 0.186 0.007 DBMET01284 0.069 0.05 DBMET01276 0.226 0.005 DBMET01285 | DBMET01275 | |
| 0.319 | 0.011 | 0.319 | Cyclooxygenase 2 inhibitor | 0.307 0.013 DBMET01274 0.244 0.021 DBMET01279 0.302 0.013 DBMET01280 0.309 0.012 DBMET01275 0.29 0.014 DBMET01284 0.235 0.023 DBMET01281 0.114 0.087 DBMET01282 0.108 0.093 DBMET01276 0.292 0.014 DBMET01285 0.103 0.101 DBMET01287 0.267 0.018 DBMET01286 0.103 0.101 DBMET01288 | ||
| 0.311 | 0.005 | 0.582 | Cyclooxygenase 3 inhibitor | 0.307 0.006 DBMET01274 0.582 0.002 DBMET01279 0.267 0.008 DBMET01280 0.413 0.004 DBMET01275 0.264 0.008 DBMET01284 0.529 0.003 DBMET01281 0.106 0.094 DBMET01276 0.35 0.005 DBMET01285 0.191 0.022 DBMET01283 0.136 0.061 DBMET01286 | DBMET01279 | |
| 0.304 | 0.005 | 0.408 | Prostaglandin antagonist | 0.337 0.005 DBMET01274 0.211 0.006 DBMET01280 0.408 0.004 DBMET01275 0.238 0.005 DBMET01284 0.08 0.023 DBMET01276 0.295 0.005 DBMET01285 0.121 0.014 DBMET01286 | DBMET01275 | |
| 0.287 | 0.005 | 0.395 | Potassium channel (Ca-activated) activator | 0.212 0.012 DBMET01274 0.089 0.065 DBMET01279 0.24 0.009 DBMET01280 0.395 0.004 DBMET01275 0.179 0.019 DBMET01284 0.093 0.062 DBMET01276 0.349 0.004 DBMET01285 | DBMET01275 | |
| 0.283 | 0.008 | 0.324 | ATPase inhibitor | 0.205 0.033 DBMET01274 0.321 0.005 DBMET01279 0.292 0.007 DBMET01280 0.235 0.018 DBMET01275 0.213 0.028 DBMET01284 0.324 0.005 DBMET01281 0.162 0.082 DBMET01282 0.244 0.015 DBMET01285 0.285 0.008 DBMET01283 | DBMET01281 | |
| 0.383 | 0.116 | 0.422 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.375 0.124 DBMET01275 0.314 0.194 DBMET01282 0.422 0.082 DBMET01276 0.295 0.219 DBMET01287 | DBMET01276 | |
| 0.326 | 0.059 | 0.435 | Lipoxygenase inhibitor | 0.338 0.055 DBMET01274 0.423 0.032 DBMET01280 0.314 0.065 DBMET01275 0.435 0.029 DBMET01284 0.221 0.121 DBMET01282 0.409 0.035 DBMET01285 0.214 0.127 DBMET01287 | DBMET01284 | |
| 0.299 | 0.033 | 0.299 | Anesthetic general | 0.25 0.05 DBMET01274 0.253 0.049 DBMET01279 0.234 0.057 DBMET01280 0.288 0.036 DBMET01275 0.185 0.083 DBMET01284 0.177 0.089 DBMET01281 0.157 0.107 DBMET01276 0.225 0.062 DBMET01285 | ||
| 0.321 | 0.06 | 0.442 | Interleukin 2 agonist | 0.39 0.03 DBMET01274 0.442 0.017 DBMET01279 0.315 0.064 DBMET01280 0.318 0.062 DBMET01275 0.381 0.034 DBMET01284 0.433 0.019 DBMET01281 0.313 0.065 DBMET01285 0.356 0.043 DBMET01283 0.213 0.168 DBMET01286 | DBMET01279 | |
| 0.295 | 0.037 | 0.295 | Gastrin inhibitor | 0.243 0.088 DBMET01274 0.22 0.119 DBMET01280 0.292 0.038 DBMET01275 0.224 0.114 DBMET01276 0.217 0.123 DBMET01285 | ||
| 0.25 | 0.013 | 0.331 | Ferrochelatase inhibitor | 0.113 0.059 DBMET01274 0.121 0.053 DBMET01280 0.331 0.005 DBMET01275 0.286 0.009 DBMET01276 0.189 0.025 DBMET01285 0.148 0.039 DBMET01287 | DBMET01275 | |
| 0.31 | 0.089 | 0.31 | Thyroid hormone antagonist | 0.294 0.096 DBMET01280 0.213 0.151 DBMET01275 0.201 0.162 DBMET01285 | ||
| 0.275 | 0.054 | 0.275 | Interleukin antagonist | 0.26 0.058 DBMET01274 0.264 0.057 DBMET01280 0.275 0.054 DBMET01275 0.252 0.061 DBMET01284 0.264 0.057 DBMET01285 | ||
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.214 0.021 DBMET01274 0.155 0.082 DBMET01279 0.225 0.014 DBMET01280 0.226 0.013 DBMET01275 0.207 0.026 DBMET01284 0.132 0.11 DBMET01281 0.22 0.017 DBMET01285 0.172 0.063 DBMET01286 | ||
| 0.29 | 0.093 | 0.29 | Thyroid hormone beta antagonist | 0.265 0.109 DBMET01280 0.193 0.16 DBMET01275 | ||
| 0.302 | 0.108 | 0.358 | Toll-Like receptor 7 agonist | 0.353 0.08 DBMET01274 0.29 0.117 DBMET01280 0.358 0.078 DBMET01275 0.338 0.088 DBMET01284 0.342 0.086 DBMET01285 | DBMET01275 | |
| 0.214 | 0.029 | 0.232 | Insulin secretagoues | 0.206 0.033 DBMET01274 0.231 0.024 DBMET01279 0.21 0.031 DBMET01280 0.232 0.023 DBMET01275 0.202 0.035 DBMET01284 0.229 0.024 DBMET01281 0.123 0.107 DBMET01276 0.225 0.025 DBMET01285 0.222 0.026 DBMET01283 0.124 0.104 DBMET01287 | DBMET01275 | |
| 0.297 | 0.113 | 0.355 | Toll-Like receptor agonist | 0.355 0.079 DBMET01274 0.282 0.122 DBMET01280 0.35 0.082 DBMET01275 0.338 0.088 DBMET01284 0.333 0.091 DBMET01285 | DBMET01274 | |
| 0.24 | 0.057 | 0.24 | ErbB-1 antagonist | 0.226 0.066 DBMET01274 0.212 0.077 DBMET01280 0.194 0.096 DBMET01275 0.201 0.088 DBMET01284 0.161 0.151 DBMET01282 0.173 0.127 DBMET01285 | ||
| 0.321 | 0.142 | 0.366 | 5 Hydroxytryptamine release inhibitor | 0.276 0.193 DBMET01279 0.278 0.191 DBMET01280 0.366 0.102 DBMET01275 0.244 0.236 DBMET01281 0.333 0.131 DBMET01276 0.322 0.141 DBMET01285 0.274 0.197 DBMET01283 0.29 0.177 DBMET01287 | DBMET01275 | |
| 0.284 | 0.108 | 0.284 | Calcium channel activator | 0.264 0.13 DBMET01274 0.217 0.189 DBMET01280 0.236 0.165 DBMET01275 | ||
| 0.171 | 0.005 | 0.171 | Sphingosine 1-phosphate receptor 4 agonist | 0.164 0.006 DBMET01274 0.135 0.012 DBMET01280 0.127 0.014 DBMET01275 0.129 0.014 DBMET01284 0.074 0.041 DBMET01282 0.079 0.038 DBMET01276 0.089 0.031 DBMET01285 | ||
| 0.274 | 0.109 | 0.482 | Cholesterol antagonist | 0.364 0.059 DBMET01274 0.482 0.036 DBMET01279 0.234 0.137 DBMET01280 0.392 0.051 DBMET01275 0.325 0.076 DBMET01284 0.39 0.052 DBMET01281 0.29 0.098 DBMET01276 0.344 0.067 DBMET01285 0.303 0.089 DBMET01283 0.251 0.124 DBMET01287 0.462 0.039 DBMET01286 0.325 0.076 DBMET01288 | DBMET01279 | |
| 0.176 | 0.016 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.163 0.024 DBMET01274 0.144 0.039 DBMET01280 0.156 0.028 DBMET01275 0.131 0.055 DBMET01284 0.125 0.064 DBMET01285 | ||
| 0.205 | 0.045 | 0.274 | Succinate dehydrogenase inhibitor | 0.184 0.063 DBMET01274 0.184 0.063 DBMET01280 0.274 0.015 DBMET01275 0.165 0.087 DBMET01284 0.19 0.057 DBMET01276 0.247 0.023 DBMET01285 0.171 0.079 DBMET01287 0.18 0.068 DBMET01286 | DBMET01275 | |
| 0.242 | 0.088 | 0.332 | 5 Hydroxytryptamine uptake stimulant | 0.236 0.095 DBMET01274 0.185 0.184 DBMET01280 0.314 0.038 DBMET01275 0.194 0.165 DBMET01282 0.332 0.031 DBMET01276 0.236 0.096 DBMET01285 0.249 0.082 DBMET01287 | DBMET01276 | |
| 0.216 | 0.065 | 0.237 | Nitric-oxide synthase stimulant | 0.237 0.042 DBMET01274 0.203 0.084 DBMET01279 0.206 0.079 DBMET01280 0.179 0.131 DBMET01275 0.227 0.052 DBMET01284 0.19 0.108 DBMET01281 0.192 0.103 DBMET01282 0.17 0.154 DBMET01285 0.188 0.11 DBMET01283 | DBMET01274 | |
| 0.154 | 0.004 | 0.218 | Dihydroorotase inhibitor | 0.065 0.014 DBMET01274 0.076 0.009 DBMET01280 0.218 0.003 DBMET01275 0.054 0.02 DBMET01276 0.105 0.005 DBMET01285 | DBMET01275 | |
| 0.176 | 0.028 | 0.189 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.072 DBMET01274 0.17 0.034 DBMET01280 0.189 0.017 DBMET01275 0.137 0.085 DBMET01284 0.134 0.091 DBMET01282 0.163 0.042 DBMET01276 0.184 0.02 DBMET01285 0.157 0.05 DBMET01287 | DBMET01275 | |
| 0.149 | 0.004 | 0.149 | Prostaglandin D2 antagonist | 0.133 0.004 DBMET01274 0.082 0.005 DBMET01280 0.127 0.004 DBMET01275 0.074 0.005 DBMET01284 0.069 0.005 DBMET01285 0.023 0.015 DBMET01286 | ||
| 0.187 | 0.046 | 0.326 | Interferon gamma antagonist | 0.158 0.069 DBMET01274 0.307 0.019 DBMET01279 0.212 0.037 DBMET01280 0.18 0.05 DBMET01275 0.174 0.054 DBMET01284 0.326 0.017 DBMET01281 0.138 0.097 DBMET01282 0.13 0.112 DBMET01276 0.203 0.04 DBMET01285 0.25 0.028 DBMET01283 0.143 0.088 DBMET01287 | DBMET01281 | |
| 0.148 | 0.007 | 0.226 | Phosphorylase inhibitor | 0.218 0.005 DBMET01274 0.221 0.004 DBMET01279 0.092 0.014 DBMET01280 0.226 0.004 DBMET01275 0.146 0.008 DBMET01284 0.141 0.008 DBMET01281 0.076 0.018 DBMET01276 0.155 0.007 DBMET01285 0.07 0.02 DBMET01283 0.042 0.035 DBMET01287 0.101 0.013 DBMET01286 | DBMET01275 | |
| 0.166 | 0.03 | 0.17 | Interleukin 1b antagonist | 0.161 0.033 DBMET01274 0.133 0.053 DBMET01280 0.17 0.028 DBMET01275 0.127 0.057 DBMET01284 0.138 0.049 DBMET01285 | DBMET01275 | |
| 0.154 | 0.019 | 0.154 | Potassium channel activator | 0.094 0.054 DBMET01274 0.102 0.045 DBMET01280 0.115 0.036 DBMET01275 | ||
| 0.133 | 0.006 | 0.176 | Dihydroorotate dehydrogenase inhibitor | 0.104 0.01 DBMET01274 0.095 0.013 DBMET01280 0.176 0.004 DBMET01275 0.07 0.022 DBMET01284 0.052 0.035 DBMET01282 0.125 0.007 DBMET01276 0.122 0.007 DBMET01285 0.09 0.014 DBMET01287 0.077 0.019 DBMET01286 0.052 0.035 DBMET01288 | DBMET01275 | |
| 0.208 | 0.089 | 0.252 | Hypolipemic | 0.232 0.076 DBMET01274 0.222 0.081 DBMET01279 0.222 0.081 DBMET01280 0.241 0.071 DBMET01275 0.244 0.07 DBMET01284 0.231 0.077 DBMET01281 0.252 0.066 DBMET01285 0.216 0.084 DBMET01283 0.183 0.107 DBMET01286 | DBMET01285 | |
| 0.238 | 0.119 | 0.256 | Nootropic | 0.256 0.103 DBMET01274 0.222 0.132 DBMET01275 0.191 0.171 DBMET01284 | DBMET01274 | |
| 0.166 | 0.048 | 0.176 | Interleukin 1 antagonist | 0.163 0.05 DBMET01274 0.119 0.09 DBMET01280 0.176 0.044 DBMET01275 0.118 0.092 DBMET01284 0.125 0.082 DBMET01285 | DBMET01275 | |
| 0.165 | 0.048 | 0.168 | MAP kinase 3 inhibitor | 0.168 0.045 DBMET01274 0.134 0.097 DBMET01280 0.146 0.074 DBMET01275 0.136 0.092 DBMET01284 | DBMET01274 | |
| 0.129 | 0.014 | 0.15 | Bile acid receptor antagonist | 0.117 0.022 DBMET01274 0.137 0.01 DBMET01280 0.14 0.009 DBMET01275 0.123 0.017 DBMET01284 0.099 0.052 DBMET01282 0.105 0.039 DBMET01276 0.15 0.007 DBMET01285 0.111 0.03 DBMET01287 0.144 0.008 DBMET01286 0.108 0.034 DBMET01288 | DBMET01285 | |
| 0.142 | 0.029 | 0.242 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.172 0.021 DBMET01274 0.131 0.033 DBMET01279 0.1 0.054 DBMET01280 0.234 0.011 DBMET01275 0.12 0.039 DBMET01284 0.096 0.058 DBMET01281 0.088 0.068 DBMET01282 0.242 0.01 DBMET01276 0.167 0.022 DBMET01285 0.127 0.035 DBMET01283 0.174 0.021 DBMET01287 | DBMET01276 | |
| 0.133 | 0.025 | 0.157 | MAP kinase kinase 1 inhibitor | 0.117 0.038 DBMET01274 0.157 0.014 DBMET01280 0.123 0.032 DBMET01275 0.138 0.022 DBMET01284 0.145 0.018 DBMET01285 | DBMET01280 | |
| 0.113 | 0.008 | 0.157 | Thromboxane antagonist | 0.125 0.006 DBMET01274 0.081 0.019 DBMET01280 0.157 0.004 DBMET01275 0.089 0.015 DBMET01284 0.107 0.009 DBMET01285 0.054 0.038 DBMET01286 | DBMET01275 | |
| 0.145 | 0.048 | 0.146 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.07 DBMET01274 0.141 0.053 DBMET01280 0.146 0.047 DBMET01275 0.128 0.078 DBMET01284 0.116 0.106 DBMET01276 0.142 0.053 DBMET01285 | DBMET01275 | |
| 0.139 | 0.043 | 0.157 | CC chemokine 6 receptor antagonist | 0.129 0.076 DBMET01274 0.157 0.015 DBMET01279 0.136 0.05 DBMET01280 0.143 0.033 DBMET01275 0.127 0.083 DBMET01284 0.154 0.018 DBMET01281 0.141 0.038 DBMET01285 0.137 0.049 DBMET01283 | DBMET01279 | |
| 0.123 | 0.028 | 0.147 | ABCA1 expression enhancer | 0.111 0.038 DBMET01274 0.113 0.036 DBMET01280 0.147 0.018 DBMET01275 0.102 0.048 DBMET01284 0.132 0.023 DBMET01285 0.1 0.05 DBMET01286 | DBMET01275 | |
| 0.101 | 0.007 | 0.141 | Thromboxane A2 antagonist | 0.109 0.006 DBMET01274 0.075 0.018 DBMET01280 0.141 0.004 DBMET01275 0.081 0.014 DBMET01284 0.095 0.009 DBMET01285 0.051 0.035 DBMET01286 | DBMET01275 | |
| 0.207 | 0.114 | 0.28 | Interleukin agonist | 0.274 0.063 DBMET01274 0.28 0.059 DBMET01279 0.264 0.069 DBMET01275 0.201 0.12 DBMET01284 0.204 0.117 DBMET01281 0.231 0.093 DBMET01276 0.19 0.13 DBMET01285 0.215 0.107 DBMET01283 | DBMET01279 | |
| 0.099 | 0.007 | 0.125 | Diacylglycerol O-acyltransferase inhibitor | 0.083 0.013 DBMET01274 0.057 0.028 DBMET01280 0.125 0.005 DBMET01275 0.045 0.044 DBMET01284 0.079 0.015 DBMET01285 | DBMET01275 | |
| 0.128 | 0.037 | 0.18 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET01274 0.139 0.028 DBMET01280 0.166 0.015 DBMET01275 0.131 0.034 DBMET01284 0.097 0.082 DBMET01282 0.126 0.039 DBMET01276 0.18 0.01 DBMET01285 0.137 0.029 DBMET01287 | DBMET01285 | |
| 0.183 | 0.093 | 0.183 | MAP kinase kinase 2 inhibitor | 0.152 0.12 DBMET01274 0.145 0.126 DBMET01280 0.14 0.131 DBMET01275 | ||
| 0.185 | 0.098 | 0.185 | EphB2 antagonist | 0.179 0.104 DBMET01280 0.145 0.134 DBMET01275 0.142 0.138 DBMET01285 | ||
| 0.163 | 0.077 | 0.183 | Catenin beta inhibitor | 0.154 0.096 DBMET01280 0.183 0.048 DBMET01275 0.15 0.107 DBMET01276 0.173 0.062 DBMET01285 0.141 0.13 DBMET01287 | DBMET01275 | |
| 0.123 | 0.038 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | 0.193 0.013 DBMET01274 0.084 0.073 DBMET01280 0.14 0.029 DBMET01275 0.143 0.028 DBMET01284 0.096 0.058 DBMET01285 | DBMET01274 | |
| 0.231 | 0.149 | 0.308 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 DBMET01274 0.281 0.097 DBMET01280 0.271 0.107 DBMET01275 0.253 0.124 DBMET01284 0.308 0.072 DBMET01285 0.268 0.11 DBMET01286 | DBMET01285 | |
| 0.103 | 0.022 | 0.154 | Potassium channel large-conductance Ca-activated activator | 0.086 0.031 DBMET01274 0.096 0.026 DBMET01280 0.154 0.01 DBMET01275 0.08 0.035 DBMET01284 0.141 0.012 DBMET01285 | DBMET01275 | |
| 0.086 | 0.007 | 0.086 | CXC chemokine 1 receptor antagonist | 0.082 0.008 DBMET01274 0.082 0.008 DBMET01280 0.079 0.009 DBMET01275 0.079 0.009 DBMET01284 0.077 0.009 DBMET01285 0.061 0.02 DBMET01286 | ||
| 0.153 | 0.076 | 0.268 | Hexokinase inhibitor | 0.157 0.071 DBMET01274 0.247 0.018 DBMET01279 0.203 0.033 DBMET01275 0.123 0.114 DBMET01284 0.202 0.034 DBMET01281 0.145 0.085 DBMET01282 0.245 0.018 DBMET01276 0.171 0.056 DBMET01285 0.268 0.014 DBMET01283 0.206 0.032 DBMET01287 | DBMET01283 | |
| 0.121 | 0.044 | 0.121 | Interleukin 2 antagonist | 0.103 0.082 DBMET01274 0.114 0.055 DBMET01275 | ||
| 0.149 | 0.075 | 0.228 | Phospholipase A2 inhibitor | 0.149 0.075 DBMET01274 0.138 0.088 DBMET01280 0.228 0.03 DBMET01275 0.138 0.088 DBMET01284 0.127 0.106 DBMET01276 0.213 0.036 DBMET01285 0.16 0.065 DBMET01286 | DBMET01275 | |
| 0.112 | 0.043 | 0.189 | Electrolyte absorption antagonist | 0.089 0.075 DBMET01280 0.189 0.01 DBMET01275 0.131 0.028 DBMET01276 0.152 0.019 DBMET01285 0.105 0.051 DBMET01287 | DBMET01275 | |
| 0.112 | 0.044 | 0.165 | DNA directed RNA polymerase inhibitor | 0.096 0.061 DBMET01274 0.129 0.032 DBMET01280 0.112 0.043 DBMET01284 0.092 0.067 DBMET01281 0.165 0.02 DBMET01282 0.101 0.056 DBMET01276 0.099 0.058 DBMET01285 0.12 0.037 DBMET01283 0.117 0.039 DBMET01287 0.09 0.069 DBMET01288 | DBMET01282 | |
| 0.108 | 0.044 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.12 0.031 DBMET01274 0.095 0.064 DBMET01275 | DBMET01274 | |
| 0.104 | 0.044 | 0.38 | Triose-phosphate isomerase inhibitor | 0.122 0.031 DBMET01274 0.137 0.024 DBMET01279 0.08 0.077 DBMET01280 0.151 0.02 DBMET01275 0.092 0.056 DBMET01284 0.103 0.045 DBMET01281 0.112 0.038 DBMET01276 0.113 0.037 DBMET01285 0.094 0.055 DBMET01283 0.085 0.067 DBMET01287 0.38 0.004 DBMET01286 0.281 0.005 DBMET01288 | DBMET01286 | |
| 0.081 | 0.022 | 0.107 | Prostaglandin F2 alpha antagonist | 0.07 0.032 DBMET01274 0.087 0.017 DBMET01280 0.103 0.01 DBMET01275 0.078 0.025 DBMET01284 0.067 0.035 DBMET01276 0.107 0.009 DBMET01285 0.076 0.026 DBMET01287 0.071 0.031 DBMET01286 | DBMET01285 | |
| 0.085 | 0.026 | 0.121 | NMDA receptor agonist | 0.057 0.052 DBMET01274 0.058 0.051 DBMET01280 0.12 0.013 DBMET01275 0.083 0.027 DBMET01285 0.121 0.013 DBMET01286 | DBMET01286 | |
| 0.084 | 0.026 | 0.104 | NMDA receptor glycine site agonist | 0.104 0.015 DBMET01275 0.068 0.038 DBMET01285 | DBMET01275 | |
| 0.068 | 0.012 | 0.09 | Carnitine palmitoyltransferase 1B inhibitor | 0.058 0.019 DBMET01274 0.055 0.022 DBMET01280 0.09 0.005 DBMET01275 0.046 0.035 DBMET01284 0.049 0.031 DBMET01276 0.072 0.01 DBMET01285 0.06 0.018 DBMET01286 | DBMET01275 | |
| 0.094 | 0.038 | 0.119 | D-Ala-D-Ala ligase inhibitor | 0.087 0.05 DBMET01274 0.09 0.044 DBMET01280 0.119 0.014 DBMET01275 0.084 0.058 DBMET01284 0.089 0.046 DBMET01276 0.114 0.017 DBMET01285 0.086 0.053 DBMET01287 | DBMET01275 | |
| 0.104 | 0.048 | 0.104 | Potassium channel (Voltage-sensitive) activator | |||
| 0.125 | 0.069 | 0.186 | MAP kinase kinase inhibitor | 0.112 0.082 DBMET01274 0.186 0.033 DBMET01280 0.124 0.07 DBMET01275 0.171 0.04 DBMET01284 0.185 0.034 DBMET01285 | DBMET01280 | |
| 0.143 | 0.088 | 0.143 | Src kinase inhibitor | 0.121 0.107 DBMET01274 0.13 0.099 DBMET01280 | ||
| 0.087 | 0.033 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.086 0.035 DBMET01274 0.073 0.062 DBMET01280 0.088 0.032 DBMET01275 0.072 0.064 DBMET01284 0.074 0.06 DBMET01285 | DBMET01275 | |
| 0.077 | 0.024 | 0.085 | MDM2 inhibitor | 0.083 0.016 DBMET01274 0.085 0.014 DBMET01275 0.079 0.021 DBMET01276 0.064 0.058 DBMET01285 | DBMET01275 | |
| 0.146 | 0.095 | 0.146 | Interleukin 6 antagonist | 0.143 0.101 DBMET01279 0.142 0.102 DBMET01283 | ||
| 0.063 | 0.015 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | 0.04 0.039 DBMET01274 0.051 0.024 DBMET01280 0.059 0.018 DBMET01275 0.047 0.028 DBMET01285 | ||
| 0.097 | 0.049 | 0.149 | NMDA receptor antagonist | 0.106 0.043 DBMET01280 0.137 0.028 DBMET01275 0.083 0.061 DBMET01282 0.123 0.034 DBMET01276 0.149 0.025 DBMET01285 0.134 0.03 DBMET01287 0.134 0.03 DBMET01286 0.12 0.035 DBMET01288 | DBMET01285 | |
| 0.128 | 0.08 | 0.128 | Lck kinase inhibitor | |||
| 0.066 | 0.019 | 0.079 | Leukotriene C antagonist | 0.069 0.015 DBMET01274 0.062 0.026 DBMET01280 0.079 0.008 DBMET01275 0.064 0.021 DBMET01284 0.073 0.011 DBMET01285 | DBMET01275 | |
| 0.085 | 0.038 | 0.098 | Peroxisome proliferator-activated receptor gamma agonist | 0.077 0.043 DBMET01274 0.087 0.036 DBMET01280 0.096 0.03 DBMET01275 0.08 0.041 DBMET01284 0.098 0.029 DBMET01285 | DBMET01285 | |
| 0.055 | 0.008 | 0.072 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.046 0.01 DBMET01274 0.031 0.019 DBMET01280 0.072 0.006 DBMET01275 0.025 0.024 DBMET01284 0.04 0.013 DBMET01285 | DBMET01275 | |
| 0.066 | 0.02 | 0.066 | DNA helicase inhibitor | 0.054 0.038 DBMET01274 0.061 0.027 DBMET01280 0.065 0.022 DBMET01275 0.059 0.029 DBMET01285 | ||
| 0.058 | 0.014 | 0.08 | Liver X receptor alpha agonist | 0.08 0.007 DBMET01274 0.056 0.015 DBMET01280 0.056 0.015 DBMET01275 0.076 0.008 DBMET01284 0.037 0.035 DBMET01282 0.04 0.03 DBMET01276 0.053 0.017 DBMET01285 0.038 0.033 DBMET01287 | DBMET01274 | |
| 0.062 | 0.02 | 0.126 | Heparanase inhibitor | 0.069 0.012 DBMET01274 0.108 0.004 DBMET01279 0.055 0.032 DBMET01280 0.082 0.006 DBMET01275 0.062 0.02 DBMET01284 0.094 0.004 DBMET01281 0.073 0.01 DBMET01285 0.075 0.009 DBMET01283 0.126 0.003 DBMET01286 0.064 0.017 DBMET01288 | DBMET01286 | |
| 0.063 | 0.022 | 0.065 | Sphingosine 1-phosphate receptor 5 agonist | 0.062 0.023 DBMET01274 0.059 0.027 DBMET01280 0.065 0.02 DBMET01275 0.058 0.028 DBMET01284 0.06 0.025 DBMET01285 | DBMET01275 | |
| 0.047 | 0.006 | 0.077 | NMDA receptor glycine site antagonist | 0.022 0.02 DBMET01274 0.031 0.012 DBMET01280 0.077 0.004 DBMET01275 0.036 0.01 DBMET01276 0.047 0.006 DBMET01285 0.023 0.018 DBMET01287 | DBMET01275 | |
| 0.16 | 0.121 | 0.204 | Growth factor agonist | 0.204 0.059 DBMET01274 0.181 0.085 DBMET01284 | DBMET01274 | |
| 0.127 | 0.088 | 0.162 | Farnesoid X receptor antagonist | 0.16 0.042 DBMET01280 0.129 0.084 DBMET01275 0.147 0.055 DBMET01284 0.127 0.088 DBMET01282 0.162 0.041 DBMET01285 0.133 0.077 DBMET01287 | DBMET01285 | |
| 0.076 | 0.039 | 0.085 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.059 DBMET01274 0.071 0.051 DBMET01280 0.085 0.028 DBMET01275 0.079 0.036 DBMET01285 | DBMET01275 | |
| 0.042 | 0.007 | 0.042 | CXC chemokine 2 receptor antagonist | 0.031 0.013 DBMET01274 0.037 0.009 DBMET01280 0.035 0.01 DBMET01275 0.028 0.016 DBMET01284 0.032 0.012 DBMET01285 | ||
| 0.075 | 0.041 | 0.083 | Elastase 1 inhibitor | 0.083 0.032 DBMET01274 0.068 0.05 DBMET01280 0.077 0.038 DBMET01275 0.076 0.04 DBMET01284 0.07 0.047 DBMET01285 | DBMET01274 | |
| 0.125 | 0.093 | 0.196 | Mannose-6-phosphate isomerase inhibitor | 0.138 0.076 DBMET01279 0.122 0.097 DBMET01275 0.164 0.053 DBMET01282 0.196 0.032 DBMET01276 0.174 0.046 DBMET01283 0.163 0.054 DBMET01287 | DBMET01276 | |
| 0.067 | 0.035 | 0.109 | Prostaglandin EP2 antagonist | 0.082 0.026 DBMET01274 0.061 0.04 DBMET01280 0.109 0.017 DBMET01275 0.075 0.029 DBMET01284 0.077 0.029 DBMET01276 0.098 0.019 DBMET01285 0.07 0.033 DBMET01287 | DBMET01275 | |
| 0.042 | 0.013 | 0.053 | Peroxisome proliferator-activated receptor delta antagonist | 0.039 0.016 DBMET01274 0.045 0.012 DBMET01280 0.049 0.01 DBMET01275 0.041 0.014 DBMET01284 0.053 0.009 DBMET01285 0.032 0.026 DBMET01286 | DBMET01285 | |
| 0.039 | 0.009 | 0.042 | Elastase 2B inhibitor | 0.042 0.007 DBMET01274 0.029 0.026 DBMET01279 0.035 0.014 DBMET01280 0.04 0.009 DBMET01275 0.038 0.01 DBMET01284 0.036 0.012 DBMET01285 0.031 0.02 DBMET01286 | DBMET01274 | |
| 0.039 | 0.009 | 0.042 | Elastase 3A inhibitor | 0.042 0.007 DBMET01274 0.029 0.026 DBMET01279 0.035 0.014 DBMET01280 0.04 0.009 DBMET01275 0.038 0.01 DBMET01284 0.036 0.012 DBMET01285 0.031 0.02 DBMET01286 | DBMET01274 | |
| 0.039 | 0.009 | 0.042 | Elastase 3B inhibitor | 0.042 0.007 DBMET01274 0.029 0.026 DBMET01279 0.035 0.014 DBMET01280 0.04 0.009 DBMET01275 0.038 0.01 DBMET01284 0.036 0.012 DBMET01285 0.031 0.02 DBMET01286 | DBMET01274 | |
| 0.107 | 0.078 | 0.132 | Cholesterol synthesis inhibitor | 0.124 0.062 DBMET01275 0.113 0.071 DBMET01276 0.109 0.076 DBMET01285 0.1 0.088 DBMET01287 0.132 0.055 DBMET01286 0.121 0.064 DBMET01288 | DBMET01286 | |
| 0.052 | 0.023 | 0.08 | NMDA receptor subunit 3B antagonist | 0.046 0.028 DBMET01280 0.08 0.014 DBMET01275 0.065 0.017 DBMET01276 0.067 0.017 DBMET01285 0.056 0.021 DBMET01287 | DBMET01275 | |
| 0.045 | 0.017 | 0.045 | Potassium channel Kv1.1 blocker | |||
| 0.06 | 0.032 | 0.078 | Aldose reductase inhibitor | 0.055 0.035 DBMET01274 0.075 0.025 DBMET01280 0.063 0.031 DBMET01275 0.07 0.027 DBMET01284 0.048 0.041 DBMET01281 0.078 0.024 DBMET01285 0.077 0.024 DBMET01286 | DBMET01285 | |
| 0.037 | 0.011 | 0.066 | Kynurenine 3 monooxygenase inhibitor | 0.059 0.005 DBMET01275 0.036 0.011 DBMET01276 0.025 0.02 DBMET01285 0.066 0.005 DBMET01286 0.04 0.01 DBMET01288 | DBMET01286 | |
| 0.094 | 0.068 | 0.138 | 5-Lipoxygenase inhibitor | 0.098 0.066 DBMET01274 0.136 0.043 DBMET01280 0.095 0.068 DBMET01275 0.138 0.043 DBMET01284 0.136 0.043 DBMET01285 | DBMET01284 | |
| 0.076 | 0.05 | 0.076 | MAP kinase 14 inhibitor | |||
| 0.068 | 0.044 | 0.068 | Potassium channel (ATP-sensitive) blocker | |||
| 0.1 | 0.076 | 0.1 | EphA2 antagonist | 0.094 0.082 DBMET01274 | ||
| 0.045 | 0.022 | 0.066 | NMDA receptor subunit 3A antagonist | 0.038 0.027 DBMET01280 0.066 0.015 DBMET01275 0.036 0.028 DBMET01276 0.053 0.019 DBMET01285 | DBMET01275 | |
| 0.074 | 0.051 | 0.146 | CDC25A inhibitor | 0.074 0.051 DBMET01274 0.072 0.054 DBMET01280 0.074 0.05 DBMET01275 0.072 0.054 DBMET01284 0.072 0.053 DBMET01285 0.146 0.013 DBMET01286 0.089 0.035 DBMET01288 | DBMET01286 | |
| 0.042 | 0.02 | 0.052 | Leukotriene C4 antagonist | 0.044 0.017 DBMET01274 0.038 0.029 DBMET01280 0.052 0.009 DBMET01275 0.04 0.024 DBMET01284 0.046 0.014 DBMET01285 | DBMET01275 | |
| 0.041 | 0.019 | 0.041 | p53 inhibitor | 0.036 0.024 DBMET01274 0.035 0.024 DBMET01275 | ||
| 0.038 | 0.018 | 0.038 | Free fatty acid receptor 1 antagonist | 0.033 0.024 DBMET01274 | ||
| 0.037 | 0.018 | 0.063 | Liver X receptor beta agonist | 0.06 0.008 DBMET01274 0.039 0.016 DBMET01280 0.036 0.019 DBMET01275 0.063 0.008 DBMET01284 0.037 0.018 DBMET01285 0.03 0.028 DBMET01287 | DBMET01284 | |
| 0.093 | 0.075 | 0.093 | Urease inhibitor | 0.092 0.077 DBMET01280 | ||
| 0.035 | 0.018 | 0.043 | ATP citrate lysase inhibitor | 0.043 0.011 DBMET01280 0.031 0.023 DBMET01275 0.03 0.026 DBMET01284 0.038 0.015 DBMET01285 | DBMET01280 | |
| 0.034 | 0.018 | 0.072 | Prostaglandin agonist | 0.05 0.01 DBMET01274 0.033 0.018 DBMET01280 0.072 0.007 DBMET01275 0.049 0.01 DBMET01284 0.039 0.014 DBMET01276 0.068 0.008 DBMET01285 0.038 0.015 DBMET01287 | DBMET01275 | |
| 0.028 | 0.012 | 0.061 | Prostaglandin E2 agonist | 0.044 0.006 DBMET01274 0.027 0.013 DBMET01280 0.061 0.005 DBMET01275 0.041 0.007 DBMET01284 0.034 0.009 DBMET01276 0.056 0.005 DBMET01285 0.032 0.01 DBMET01287 | DBMET01275 | |
| 0.062 | 0.047 | 0.077 | CDC25B inhibitor | 0.068 0.04 DBMET01274 0.068 0.04 DBMET01279 0.06 0.051 DBMET01280 0.077 0.03 DBMET01275 0.065 0.044 DBMET01284 0.064 0.045 DBMET01281 0.074 0.034 DBMET01285 | DBMET01275 | |
| 0.028 | 0.013 | 0.049 | Prostaglandin EP2 agonist | 0.042 0.008 DBMET01274 0.025 0.015 DBMET01280 0.049 0.006 DBMET01275 0.04 0.008 DBMET01284 0.028 0.013 DBMET01276 0.047 0.006 DBMET01285 0.024 0.015 DBMET01287 | DBMET01275 | |
| 0.101 | 0.087 | 0.189 | Cell adhesion inhibitor | 0.101 0.087 DBMET01274 0.189 0.028 DBMET01279 0.119 0.066 DBMET01275 0.16 0.041 DBMET01281 0.114 0.07 DBMET01283 | DBMET01279 | |
| 0.041 | 0.028 | 0.089 | Kainate receptor antagonist | 0.089 0.009 DBMET01275 0.051 0.021 DBMET01276 0.067 0.013 DBMET01285 0.038 0.031 DBMET01287 | DBMET01275 | |
| 0.094 | 0.082 | 0.185 | Protein kinase (CK2) alpha inhibitor | 0.098 0.078 DBMET01280 0.18 0.029 DBMET01275 0.185 0.028 DBMET01285 | DBMET01285 | |
| 0.035 | 0.022 | 0.046 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 DBMET01274 0.046 0.011 DBMET01275 0.038 0.019 DBMET01285 | DBMET01275 | |
| 0.037 | 0.025 | 0.043 | Integrin alpha2 antagonist | 0.036 0.027 DBMET01274 0.043 0.017 DBMET01275 0.035 0.029 DBMET01276 | DBMET01275 | |
| 0.055 | 0.044 | 0.083 | Pregnane X receptor antagonist | 0.065 0.022 DBMET01280 0.058 0.036 DBMET01275 0.08 0.007 DBMET01282 0.072 0.012 DBMET01276 0.067 0.017 DBMET01285 0.083 0.005 DBMET01287 | DBMET01287 | |
| 0.054 | 0.043 | 0.097 | Adenine nucleotide translocase inhibitor | 0.087 0.007 DBMET01279 0.061 0.026 DBMET01280 0.069 0.016 DBMET01275 0.055 0.039 DBMET01284 0.09 0.006 DBMET01281 0.061 0.026 DBMET01276 0.076 0.011 DBMET01285 0.063 0.023 DBMET01283 0.069 0.016 DBMET01287 0.097 0.005 DBMET01286 0.091 0.005 DBMET01288 | DBMET01286 | |
| 0.104 | 0.093 | 0.262 | Amylase inhibitor | 0.145 0.067 DBMET01274 0.262 0.025 DBMET01279 0.102 0.094 DBMET01280 0.143 0.067 DBMET01284 0.245 0.029 DBMET01281 0.25 0.028 DBMET01283 | DBMET01279 | |
| 0.058 | 0.048 | 0.061 | NMDA 2C receptor antagonist | 0.06 0.045 DBMET01275 0.061 0.043 DBMET01276 0.055 0.052 DBMET01287 | DBMET01276 | |
| 0.03 | 0.019 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 DBMET01274 0.036 0.015 DBMET01275 0.043 0.011 DBMET01284 0.044 0.011 DBMET01276 0.025 0.023 DBMET01285 0.033 0.017 DBMET01287 | DBMET01274 | |
| 0.072 | 0.062 | 0.081 | GABA B receptor agonist | 0.081 0.04 DBMET01275 0.077 0.049 DBMET01285 | DBMET01275 | |
| 0.072 | 0.062 | 0.173 | Keratolytic | 0.083 0.045 DBMET01274 0.09 0.037 DBMET01280 0.121 0.021 DBMET01275 0.108 0.026 DBMET01284 0.173 0.011 DBMET01285 0.074 0.058 DBMET01287 | DBMET01285 | |
| 0.035 | 0.026 | 0.041 | Glutamate (mGluR8) antagonist | 0.041 0.015 DBMET01275 0.038 0.019 DBMET01285 | DBMET01275 | |
| 0.19 | 0.181 | 0.396 | Angiogenesis inhibitor | 0.329 0.08 DBMET01279 0.22 0.148 DBMET01280 0.214 0.153 DBMET01284 0.356 0.069 DBMET01281 0.201 0.169 DBMET01285 0.209 0.159 DBMET01283 0.396 0.054 DBMET01286 0.244 0.128 DBMET01288 | DBMET01286 | |
| 0.018 | 0.009 | 0.023 | Thyroid hormone alpha agonist | 0.016 0.012 DBMET01274 0.023 0.005 DBMET01280 0.016 0.013 DBMET01275 0.021 0.006 DBMET01284 0.02 0.007 DBMET01285 | DBMET01280 | |
| 0.087 | 0.079 | 0.096 | Interleukin 12 antagonist | 0.091 0.07 DBMET01274 0.087 0.08 DBMET01279 0.092 0.068 DBMET01280 0.096 0.061 DBMET01284 0.089 0.075 DBMET01281 | DBMET01284 | |
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | 0.017 0.012 DBMET01274 | ||
| 0.056 | 0.05 | 0.12 | Purinergic P2X1 antagonist | 0.06 0.044 DBMET01274 0.066 0.036 DBMET01280 0.102 0.016 DBMET01275 0.071 0.031 DBMET01284 0.12 0.012 DBMET01285 0.058 0.047 DBMET01287 0.061 0.042 DBMET01286 | DBMET01285 | |
| 0.04 | 0.034 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 DBMET01280 0.057 0.009 DBMET01275 0.05 0.015 DBMET01276 0.06 0.008 DBMET01285 0.052 0.013 DBMET01287 | DBMET01285 | |
| 0.031 | 0.026 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.028 | 0.022 | 0.059 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET01275 0.059 0.006 DBMET01276 0.028 0.022 DBMET01285 0.038 0.015 DBMET01287 | DBMET01276 | |
| 0.104 | 0.099 | 0.104 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.036 | 0.031 | 0.05 | Glutamate (mGluR8) agonist | 0.035 0.032 DBMET01274 0.036 0.032 DBMET01280 0.05 0.012 DBMET01275 0.035 0.033 DBMET01284 0.05 0.012 DBMET01285 | DBMET01285 | |
| 0.047 | 0.043 | 0.047 | Potassium channel (Inward rectifier) activator | |||
| 0.027 | 0.023 | 0.039 | Liver X receptor alpha antagonist | 0.039 0.01 DBMET01274 0.027 0.024 DBMET01280 0.029 0.02 DBMET01275 0.038 0.01 DBMET01284 0.027 0.023 DBMET01276 0.029 0.02 DBMET01285 0.027 0.024 DBMET01287 | DBMET01274 | |
| 0.024 | 0.021 | 0.047 | Thyroid hormone agonist | 0.047 0.005 DBMET01280 0.044 0.005 DBMET01284 0.032 0.01 DBMET01285 0.035 0.009 DBMET01286 | DBMET01280 | |
| 0.045 | 0.041 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.015 | 0.012 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.042 | 0.04 | 0.05 | Peroxisome proliferator-activated receptor alpha agonist | 0.05 0.032 DBMET01275 0.046 0.035 DBMET01285 | DBMET01275 | |
| 0.044 | 0.042 | 0.121 | Prostaglandin E2 antagonist | 0.074 0.022 DBMET01274 0.121 0.011 DBMET01275 0.049 0.036 DBMET01284 0.121 0.011 DBMET01276 0.08 0.02 DBMET01285 0.079 0.02 DBMET01287 | DBMET01276 | |
| 0.024 | 0.023 | 0.029 | Integrin alpha2beta1 antagonist | 0.025 0.022 DBMET01274 0.029 0.014 DBMET01275 0.027 0.016 DBMET01276 | DBMET01275 | |
| 0.031 | 0.03 | 0.036 | Glutamate (mGluR4) agonist | 0.036 0.02 DBMET01275 | DBMET01275 | |
| 0.044 | 0.043 | 0.056 | NMDA 2A receptor antagonist | 0.056 0.032 DBMET01275 0.052 0.036 DBMET01285 | DBMET01275 | |
| 0.023 | 0.022 | 0.046 | Prostaglandin EP4 antagonist | 0.03 0.015 DBMET01274 0.046 0.009 DBMET01275 0.025 0.019 DBMET01284 0.03 0.015 DBMET01276 0.038 0.012 DBMET01285 0.025 0.019 DBMET01287 | DBMET01275 | |
| 0.026 | 0.025 | 0.031 | Prostaglandin EP3 antagonist | 0.031 0.021 DBMET01274 0.028 0.024 DBMET01275 0.026 0.025 DBMET01284 | DBMET01274 | |
| 0.03 | 0.03 | 0.057 | Purinergic P2Y2 antagonist | 0.034 0.023 DBMET01275 0.03 0.029 DBMET01285 0.057 0.008 DBMET01286 0.039 0.017 DBMET01288 | DBMET01286 | |
| 0.013 | 0.015 | 0.019 | Thyroid hormone alpha antagonist | 0.019 0.008 DBMET01280 0.017 0.01 DBMET01284 0.019 0.008 DBMET01285 | DBMET01285 | |
| 0.03 | 0.032 | 0.052 | Carnitine palmitoyltransferase inhibitor | 0.052 0.007 DBMET01275 0.047 0.01 DBMET01276 0.032 0.026 DBMET01285 | DBMET01275 | |
| 0.03 | 0.032 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.008 DBMET01275 0.046 0.01 DBMET01276 | DBMET01275 | |
| 0.026 | 0.029 | 0.038 | Liver X receptor antagonist | 0.038 0.015 DBMET01274 0.027 0.026 DBMET01275 0.036 0.017 DBMET01284 | DBMET01274 | |
| 0.037 | 0.04 | 0.097 | Glutamate (mGluR group III) agonist | 0.051 0.023 DBMET01275 0.097 0.01 DBMET01276 0.052 0.022 DBMET01287 | DBMET01276 | |
| 0.084 | 0.088 | 0.173 | GABA C receptor agonist | 0.173 0.026 DBMET01275 0.155 0.032 DBMET01285 | DBMET01275 | |
| 0.037 | 0.042 | 0.047 | Liver X receptor agonist | 0.047 0.025 DBMET01274 0.047 0.025 DBMET01284 | DBMET01284 | |
| 0.031 | 0.036 | 0.049 | Glutamate (mGluR3) antagonist | 0.034 0.03 DBMET01274 0.049 0.013 DBMET01275 0.039 0.022 DBMET01276 0.033 0.032 DBMET01285 | DBMET01275 | |
| 0.059 | 0.064 | 0.14 | NMDA 2 receptor antagonist | 0.067 0.054 DBMET01280 0.076 0.046 DBMET01275 0.079 0.044 DBMET01282 0.089 0.038 DBMET01276 0.088 0.039 DBMET01285 0.101 0.031 DBMET01287 0.123 0.023 DBMET01286 0.14 0.019 DBMET01288 | DBMET01288 | |
| 0.015 | 0.021 | 0.049 | Kainate receptor 1 antagonist | 0.049 0.005 DBMET01275 0.031 0.01 DBMET01276 0.032 0.009 DBMET01285 0.018 0.017 DBMET01287 | DBMET01275 | |
| 0.087 | 0.094 | 0.144 | Cystathionine beta-synthase inhibitor | 0.103 0.073 DBMET01280 0.122 0.056 DBMET01275 0.107 0.07 DBMET01276 0.144 0.043 DBMET01285 0.126 0.054 DBMET01287 | DBMET01285 | |
| 0.021 | 0.028 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.023 DBMET01275 | DBMET01275 | |
| 0.059 | 0.066 | 0.151 | Catalase inhibitor | 0.078 0.049 DBMET01274 0.128 0.031 DBMET01275 0.081 0.047 DBMET01285 0.151 0.026 DBMET01286 | DBMET01286 | |
| 0.06 | 0.068 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.037 DBMET01275 0.062 0.061 DBMET01276 0.062 0.059 DBMET01285 | DBMET01275 | |
| 0.005 | 0.013 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET01280 0.011 0.005 DBMET01284 | DBMET01280 | |
| 0.049 | 0.057 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.047 DBMET01274 | DBMET01274 | |
| 0.076 | 0.084 | 0.08 | T cell inhibitor | 0.08 0.066 DBMET01279 | DBMET01279 | |
| 0.033 | 0.043 | 0.052 | AMPA 4 receptor antagonist | 0.045 0.019 DBMET01275 0.052 0.013 DBMET01276 0.04 0.026 DBMET01285 0.046 0.018 DBMET01287 | DBMET01276 | |
| 0.247 | 0.257 | 0.338 | Caspase 9 stimulant | 0.309 0.184 DBMET01274 0.338 0.155 DBMET01279 0.298 0.196 DBMET01284 0.315 0.178 DBMET01281 | DBMET01279 | |
| 0.008 | 0.018 | 0.018 | Thrombopoietin agonist | 0.013 0.006 DBMET01275 0.018 0.004 DBMET01276 0.012 0.007 DBMET01287 | DBMET01276 | |
| 0.012 | 0.022 | 0.016 | Free fatty acid receptor 1 agonist | 0.016 0.014 DBMET01274 0.016 0.014 DBMET01284 | DBMET01284 | |
| 0.015 | 0.026 | 0.032 | Retinoid X beta receptor agonist | 0.032 0.008 DBMET01275 0.019 0.017 DBMET01276 0.024 0.011 DBMET01285 | DBMET01275 | |
| 0.067 | 0.078 | 0.114 | Cell adhesion molecule inhibitor | 0.114 0.027 DBMET01279 0.076 0.058 DBMET01275 0.091 0.042 DBMET01281 | DBMET01279 | |
| 0.008 | 0.019 | 0.036 | Prostaglandin EP4 agonist | 0.032 0.007 DBMET01275 0.036 0.006 DBMET01276 | DBMET01276 | |
| 0.052 | 0.064 | 0.092 | Leukotriene antagonist | 0.07 0.04 DBMET01274 0.092 0.025 DBMET01275 0.062 0.048 DBMET01284 0.082 0.03 DBMET01285 0.066 0.044 DBMET01286 | DBMET01275 | |
| 0.096 | 0.109 | 0.12 | M17 leucyl aminopeptidase inhibitor | 0.12 0.078 DBMET01275 0.108 0.091 DBMET01285 | DBMET01275 | |
| 0.084 | 0.097 | 0.125 | Carbonic anhydrase XV inhibitor | 0.114 0.052 DBMET01274 0.091 0.082 DBMET01280 0.111 0.055 DBMET01275 0.125 0.043 DBMET01284 0.121 0.045 DBMET01285 | DBMET01284 | |
| 0.016 | 0.031 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET01275 | DBMET01275 | |
| 0.052 | 0.068 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 DBMET01274 | DBMET01274 | |
| 0.021 | 0.038 | 0.032 | Carnitine palmitoyltransferase 1A inhibitor | 0.032 0.015 DBMET01275 0.028 0.021 DBMET01276 | DBMET01275 | |
| 0.015 | 0.033 | 0.033 | Retinoid X gamma receptor agonist | 0.033 0.009 DBMET01275 0.021 0.019 DBMET01276 0.026 0.013 DBMET01285 | DBMET01275 | |
| 0.013 | 0.031 | 0.017 | Complement factor D inhibitor | 0.017 0.016 DBMET01274 | DBMET01274 | |
| 0.01 | 0.028 | 0.03 | Prostaglandin EP1 antagonist | 0.03 0.01 DBMET01275 0.017 0.016 DBMET01285 | DBMET01275 | |
| 0.076 | 0.094 | 0.204 | Creatine kinase inhibitor | 0.087 0.077 DBMET01280 0.108 0.051 DBMET01275 0.151 0.024 DBMET01282 0.186 0.013 DBMET01276 0.121 0.041 DBMET01285 0.204 0.01 DBMET01287 0.085 0.079 DBMET01288 | DBMET01287 | |
| 0.029 | 0.05 | 0.04 | Retinoid X receptor antagonist | 0.04 0.023 DBMET01275 | DBMET01275 | |
| 0.026 | 0.048 | 0.036 | Retinoid X alpha receptor antagonist | 0.036 0.02 DBMET01275 | DBMET01275 | |
| 0.126 | 0.148 | 0.179 | Lipocortins synthesis antagonist | 0.179 0.072 DBMET01275 0.166 0.085 DBMET01276 0.166 0.085 DBMET01285 0.153 0.1 DBMET01287 | DBMET01275 | |
| 0.056 | 0.078 | 0.147 | Glutamate decarboxylase inhibitor | 0.069 0.057 DBMET01280 0.122 0.02 DBMET01275 0.147 0.014 DBMET01285 | DBMET01285 | |
| 0.024 | 0.049 | 0.074 | Farnesoid X receptor agonist | 0.053 0.013 DBMET01275 0.074 0.006 DBMET01276 0.044 0.019 DBMET01285 0.064 0.009 DBMET01287 0.052 0.013 DBMET01286 0.074 0.006 DBMET01288 | DBMET01288 | |
| 0.138 | 0.163 | 0.313 | Antiamyloidogenic | 0.241 0.075 DBMET01279 0.198 0.101 DBMET01280 0.192 0.105 DBMET01275 0.21 0.093 DBMET01284 0.313 0.048 DBMET01281 0.271 0.062 DBMET01285 | DBMET01281 | |
| 0.039 | 0.064 | 0.099 | Factor IXa inhibitor | 0.088 0.013 DBMET01279 0.077 0.017 DBMET01281 0.055 0.031 DBMET01283 0.099 0.01 DBMET01286 0.07 0.02 DBMET01288 | DBMET01286 | |
| 0.014 | 0.04 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.014 DBMET01275 | DBMET01275 | |
| 0.016 | 0.042 | 0.041 | AMPA 2 receptor antagonist | 0.026 0.024 DBMET01275 0.041 0.014 DBMET01276 0.03 0.02 DBMET01287 | DBMET01276 | |
| 0.059 | 0.086 | 0.091 | GABA aminotransferase inhibitor | 0.091 0.034 DBMET01275 0.081 0.045 DBMET01276 0.081 0.045 DBMET01285 0.072 0.058 DBMET01287 | DBMET01275 | |
| 0.028 | 0.055 | 0.047 | Purinergic P2Y antagonist | 0.047 0.029 DBMET01275 | DBMET01275 | |
| 0.022 | 0.049 | 0.034 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET01275 | DBMET01275 | |
| 0.189 | 0.216 | 0.351 | Histamine release inhibitor | 0.213 0.187 DBMET01279 0.351 0.099 DBMET01275 0.241 0.162 DBMET01276 0.324 0.112 DBMET01285 0.222 0.179 DBMET01287 0.219 0.181 DBMET01286 | DBMET01275 | |
| 0.097 | 0.124 | 0.149 | Interleukin 4 antagonist | 0.131 0.07 DBMET01279 0.133 0.068 DBMET01280 0.118 0.088 DBMET01275 0.126 0.077 DBMET01284 0.146 0.053 DBMET01281 0.149 0.05 DBMET01285 | DBMET01285 | |
| 0.051 | 0.078 | 0.159 | Carbonic anhydrase VA inhibitor | 0.065 0.052 DBMET01274 0.069 0.047 DBMET01284 0.063 0.055 DBMET01285 0.159 0.009 DBMET01286 | DBMET01286 | |
| 0.068 | 0.096 | 0.133 | Aminopeptidase B inhibitor | 0.109 0.059 DBMET01275 0.09 0.072 DBMET01285 0.133 0.045 DBMET01286 | DBMET01286 | |
| 0.012 | 0.041 | 0.05 | AMPA 1 receptor antagonist | 0.043 0.013 DBMET01275 0.05 0.011 DBMET01276 0.029 0.021 DBMET01285 0.035 0.017 DBMET01287 | DBMET01276 | |
| 0.019 | 0.048 | 0.036 | Retinoid X receptor agonist | 0.036 0.024 DBMET01275 | DBMET01275 | |
| 0.019 | 0.05 | 0.061 | Kainate receptor 2 antagonist | 0.035 0.025 DBMET01275 0.061 0.011 DBMET01276 0.034 0.026 DBMET01287 | DBMET01276 | |
| 0.043 | 0.074 | 0.056 | Sphingosine 1-phosphate receptor 3 antagonist | 0.056 0.044 DBMET01275 | DBMET01275 | |
| 0.025 | 0.056 | 0.041 | Urate transporter 1 inhibitor | 0.041 0.024 DBMET01285 | DBMET01285 | |
| 0.161 | 0.193 | 0.188 | 12-Lipoxygenase inhibitor | 0.188 0.165 DBMET01280 | DBMET01280 | |
| 0.04 | 0.076 | 0.066 | p38 MAP kinase inhibitor | 0.066 0.047 DBMET01282 0.056 0.055 DBMET01276 | DBMET01282 | |
| 0.067 | 0.103 | 0.152 | Protein kinase (CK2) inhibitor | 0.152 0.032 DBMET01275 0.15 0.033 DBMET01285 | DBMET01275 | |
| 0.048 | 0.084 | 0.189 | Histidine decarboxylase inhibitor | 0.125 0.024 DBMET01274 0.062 0.06 DBMET01280 0.137 0.022 DBMET01275 0.175 0.016 DBMET01284 0.189 0.014 DBMET01285 | DBMET01285 | |
| 0.017 | 0.055 | 0.026 | Calcium-sensing receptor agonist | 0.026 0.02 DBMET01275 | DBMET01275 | |
| 0.123 | 0.162 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.131 0.112 DBMET01279 0.133 0.103 DBMET01275 0.129 0.127 DBMET01282 0.147 0.05 DBMET01276 0.142 0.067 DBMET01287 | DBMET01276 | |
| 0.079 | 0.119 | 0.172 | Toll-Like receptor 4 antagonist | 0.094 0.08 DBMET01274 0.172 0.012 DBMET01279 0.092 0.084 DBMET01284 0.168 0.013 DBMET01281 0.128 0.036 DBMET01283 | DBMET01279 | |
| 0.034 | 0.076 | 0.051 | Maillard reaction inhibitor | 0.051 0.042 DBMET01285 | DBMET01285 | |
| 0.026 | 0.069 | 0.033 | Tryptophan 5 hydroxylase inhibitor | 0.033 0.032 DBMET01276 | DBMET01276 | |
| 0.018 | 0.061 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET01275 0.027 0.019 DBMET01276 | DBMET01276 | |
| 0.106 | 0.15 | 0.347 | Dual specificity phosphatase 3 inhibitor | 0.148 0.098 DBMET01275 0.161 0.087 DBMET01285 0.137 0.108 DBMET01287 0.347 0.021 DBMET01286 0.333 0.023 DBMET01288 | DBMET01286 | |
| 0.172 | 0.216 | 0.413 | Antithrombotic | 0.226 0.148 DBMET01274 0.383 0.054 DBMET01279 0.239 0.135 DBMET01275 0.206 0.17 DBMET01284 0.347 0.066 DBMET01281 0.219 0.155 DBMET01285 0.387 0.053 DBMET01283 0.413 0.046 DBMET01286 0.284 0.099 DBMET01288 | DBMET01286 | |
| 0.052 | 0.099 | 0.101 | HIV-1 integrase inhibitor | 0.07 0.048 DBMET01276 0.073 0.045 DBMET01287 0.088 0.032 DBMET01286 0.101 0.024 DBMET01288 | DBMET01288 | |
| 0.041 | 0.089 | 0.205 | Carbonic anhydrase V inhibitor | 0.061 0.053 DBMET01274 0.065 0.048 DBMET01284 0.205 0.006 DBMET01286 0.095 0.029 DBMET01288 | DBMET01286 | |
| 0.076 | 0.124 | 0.261 | Beta glucuronidase inhibitor | 0.261 0.008 DBMET01279 0.219 0.011 DBMET01281 0.179 0.016 DBMET01283 | DBMET01279 | |
| 0.078 | 0.127 | 0.245 | Multidrug resistance-associated protein 1 inhibitor | 0.154 0.024 DBMET01279 0.093 0.091 DBMET01275 0.141 0.03 DBMET01281 0.121 0.047 DBMET01282 0.149 0.026 DBMET01276 0.133 0.036 DBMET01283 0.13 0.038 DBMET01287 0.21 0.008 DBMET01286 0.245 0.005 DBMET01288 | DBMET01288 | |
| 0.034 | 0.087 | 0.073 | Aconitate hydratase inhibitor | 0.073 0.017 DBMET01275 0.053 0.034 DBMET01276 0.053 0.035 DBMET01285 | DBMET01275 | |
| 0.075 | 0.129 | 0.11 | M18 aspartyl aminopeptidase inhibitor | 0.109 0.081 DBMET01280 0.11 0.08 DBMET01285 | DBMET01285 | |
| 0.078 | 0.131 | 0.094 | Folate antagonist | 0.094 0.077 DBMET01285 | DBMET01285 | |
| 0.022 | 0.077 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.022 DBMET01285 | DBMET01285 | |
| 0.01 | 0.065 | 0.028 | Methionyl aminopeptidase 2 inhibitor | 0.028 0.015 DBMET01276 | DBMET01276 | |
| 0.034 | 0.089 | 0.054 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.036 DBMET01282 0.05 0.043 DBMET01287 | DBMET01282 | |
| 0.125 | 0.181 | 0.161 | Neurotrophic factor enhancer | 0.156 0.13 DBMET01282 0.161 0.122 DBMET01283 | DBMET01283 | |
| 0.024 | 0.083 | 0.051 | Retinoic acid alpha receptor agonist | 0.051 0.013 DBMET01275 0.051 0.013 DBMET01276 0.048 0.016 DBMET01285 0.047 0.016 DBMET01287 | DBMET01276 | |
| 0.079 | 0.14 | 0.174 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.089 DBMET01274 0.174 0.043 DBMET01275 0.15 0.055 DBMET01276 0.144 0.058 DBMET01285 0.124 0.074 DBMET01287 | DBMET01275 | |
| 0.011 | 0.073 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.011 DBMET01275 0.02 0.013 DBMET01276 0.019 0.014 DBMET01285 0.019 0.017 DBMET01287 | DBMET01275 | |
| 0.038 | 0.103 | 0.102 | MAP kinase 11 inhibitor | 0.099 0.036 DBMET01282 0.102 0.034 DBMET01276 | DBMET01276 | |
| 0.053 | 0.118 | 0.087 | Carbonic anhydrase VI inhibitor | 0.075 0.064 DBMET01274 0.071 0.07 DBMET01275 0.087 0.049 DBMET01284 0.083 0.053 DBMET01285 0.073 0.067 DBMET01286 | DBMET01284 | |
| 0.016 | 0.082 | 0.055 | TRPM8 blocker | 0.055 0.013 DBMET01276 | DBMET01276 | |
| 0.008 | 0.074 | 0.031 | Kainate receptor 5 antagonist | 0.031 0.009 DBMET01276 0.02 0.015 DBMET01287 | DBMET01276 | |
| 0.07 | 0.137 | 0.092 | Glutamate release inhibitor | 0.092 0.058 DBMET01274 0.083 0.08 DBMET01284 | DBMET01274 | |
| 0.16 | 0.227 | 0.19 | Tyrosine 3 hydroxylase inhibitor | 0.19 0.155 DBMET01280 | DBMET01280 | |
| 0.077 | 0.147 | 0.114 | TRPA1 agonist | 0.11 0.072 DBMET01282 0.114 0.066 DBMET01276 0.103 0.082 DBMET01287 | DBMET01276 | |
| 0.074 | 0.144 | 0.115 | Caspase 3 inhibitor | 0.115 0.067 DBMET01276 | DBMET01276 | |
| 0.06 | 0.131 | 0.084 | Ephrin antagonist | 0.084 0.079 DBMET01274 | DBMET01274 | |
| 0.058 | 0.13 | 0.208 | Alcohol dehydrogenase inhibitor | 0.085 0.071 DBMET01280 0.099 0.054 DBMET01275 0.103 0.049 DBMET01282 0.134 0.026 DBMET01276 0.136 0.026 DBMET01285 0.208 0.011 DBMET01287 | DBMET01287 | |
| 0.049 | 0.121 | 0.07 | Beta 2 adrenoreceptor agonist | 0.063 0.036 DBMET01274 0.07 0.019 DBMET01284 | DBMET01284 | |
| 0.075 | 0.148 | 0.144 | Nav1.5 sodium channel blocker | 0.144 0.03 DBMET01282 | DBMET01282 | |
| 0.071 | 0.144 | 0.134 | MAP kinase 12 inhibitor | 0.127 0.062 DBMET01282 0.134 0.054 DBMET01276 | DBMET01276 | |
| 0.099 | 0.173 | 0.398 | Hemostatic | 0.119 0.117 DBMET01274 0.199 0.033 DBMET01279 0.122 0.11 DBMET01275 0.194 0.035 DBMET01281 0.119 0.115 DBMET01285 0.281 0.018 DBMET01283 0.398 0.008 DBMET01286 0.341 0.012 DBMET01288 | DBMET01286 | |
| 0.077 | 0.151 | 0.148 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 DBMET01282 0.14 0.054 DBMET01276 0.148 0.048 DBMET01287 | DBMET01287 | |
| 0.072 | 0.147 | 0.108 | Adenylate kinase inhibitor | 0.108 0.055 DBMET01275 0.098 0.071 DBMET01285 | DBMET01275 | |
| 0.151 | 0.226 | 0.561 | Transcription factor NF kappa B inhibitor | 0.55 0.038 DBMET01279 0.193 0.176 DBMET01284 0.561 0.036 DBMET01281 0.48 0.047 DBMET01283 0.206 0.163 DBMET01287 | DBMET01281 | |
| 0.049 | 0.125 | 0.115 | Adrenaline agonist | 0.087 0.049 DBMET01274 0.115 0.028 DBMET01284 0.087 0.049 DBMET01285 | DBMET01284 | |
| 0.078 | 0.155 | 0.121 | Toll-Like receptor 2 antagonist | 0.104 0.098 DBMET01274 0.121 0.077 DBMET01284 | DBMET01284 | |
| 0.007 | 0.084 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 DBMET01276 0.02 0.009 DBMET01287 | DBMET01287 | |
| 0.034 | 0.112 | 0.072 | Autotaxin inhibitor | 0.054 0.034 DBMET01275 0.052 0.037 DBMET01285 0.072 0.022 DBMET01286 0.055 0.033 DBMET01288 | DBMET01286 | |
| 0.03 | 0.108 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 DBMET01275 | DBMET01275 | |
| 0.11 | 0.189 | 0.199 | Aldehyde oxidase inhibitor | 0.171 0.122 DBMET01275 0.199 0.105 DBMET01285 | DBMET01285 | |
| 0.046 | 0.124 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.053 DBMET01275 0.066 0.063 DBMET01285 | DBMET01275 | |
| 0.004 | 0.084 | 0.025 | Egl nine homolog 1 inhibitor | 0.018 0.007 DBMET01276 0.025 0.004 DBMET01287 | DBMET01287 | |
| 0.012 | 0.093 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.016 DBMET01275 0.021 0.019 DBMET01276 0.022 0.017 DBMET01285 0.021 0.02 DBMET01287 | DBMET01285 | |
| 0.03 | 0.111 | 0.056 | Leukotriene B4 antagonist | 0.049 0.046 DBMET01285 0.056 0.034 DBMET01286 | DBMET01286 | |
| 0.033 | 0.114 | 0.049 | Beta adrenoreceptor agonist | 0.044 0.038 DBMET01274 0.049 0.02 DBMET01284 0.045 0.032 DBMET01285 | DBMET01284 | |
| 0.069 | 0.151 | 0.113 | Nav1.4 sodium channel blocker | 0.103 0.072 DBMET01284 0.113 0.059 DBMET01286 | DBMET01286 | |
| 0.037 | 0.12 | 0.211 | Glutamate receptor agonist | 0.096 0.04 DBMET01282 0.211 0.009 DBMET01276 0.148 0.018 DBMET01287 0.074 0.059 DBMET01288 | DBMET01276 | |
| 0.013 | 0.096 | 0.143 | Nicotinic acid receptor agonist | 0.038 0.023 DBMET01275 0.04 0.02 DBMET01282 0.086 0.005 DBMET01276 0.067 0.009 DBMET01285 0.143 0.004 DBMET01287 | DBMET01287 | |
| 0.037 | 0.121 | 0.231 | Carbonic anhydrase XIII inhibitor | 0.078 0.051 DBMET01284 0.069 0.059 DBMET01285 0.231 0.01 DBMET01286 0.133 0.026 DBMET01288 | DBMET01286 | |
| 0.047 | 0.131 | 0.17 | Macrophage migration inhibitory factor inhibitor | 0.073 0.061 DBMET01280 0.072 0.063 DBMET01284 0.129 0.022 DBMET01282 0.106 0.031 DBMET01276 0.095 0.038 DBMET01285 0.17 0.011 DBMET01287 | DBMET01287 | |
| 0.049 | 0.134 | 0.165 | Glycine receptor antagonist | 0.116 0.021 DBMET01282 0.151 0.007 DBMET01276 0.165 0.005 DBMET01283 0.111 0.024 DBMET01287 0.164 0.005 DBMET01288 | DBMET01283 | |
| 0.115 | 0.202 | 0.154 | Phospholipase C inhibitor | 0.137 0.136 DBMET01274 0.15 0.106 DBMET01284 0.147 0.111 DBMET01285 0.154 0.098 DBMET01286 | DBMET01286 | |
| 0.077 | 0.163 | 0.185 | NADPH oxidase inhibitor | 0.125 0.077 DBMET01282 0.185 0.039 DBMET01276 0.133 0.069 DBMET01287 | DBMET01276 | |
| 0.06 | 0.147 | 0.126 | Transcription factor NF kappa B stimulant | 0.087 0.056 DBMET01274 0.118 0.026 DBMET01279 0.099 0.039 DBMET01284 0.126 0.023 DBMET01281 0.082 0.066 DBMET01285 0.113 0.029 DBMET01283 | DBMET01281 | |
| 0.018 | 0.105 | 0.058 | Glutamate (mGluR group I) agonist | 0.051 0.029 DBMET01282 0.058 0.024 DBMET01276 | DBMET01276 | |
| 0.039 | 0.126 | 0.109 | Cathepsin G inhibitor | 0.088 0.039 DBMET01286 0.109 0.03 DBMET01288 | DBMET01288 | |
| 0.109 | 0.197 | 0.135 | MAP kinase kinase 4 inhibitor | 0.129 0.118 DBMET01275 0.131 0.11 DBMET01276 0.132 0.107 DBMET01285 0.135 0.099 DBMET01287 | DBMET01287 | |
| 0.066 | 0.155 | 0.444 | AMP-activated protein kinase stimulant | 0.143 0.033 DBMET01279 0.09 0.086 DBMET01280 0.109 0.06 DBMET01275 0.113 0.056 DBMET01284 0.169 0.018 DBMET01281 0.15 0.028 DBMET01282 0.177 0.015 DBMET01276 0.149 0.029 DBMET01285 0.444 0.004 DBMET01283 0.241 0.007 DBMET01287 | DBMET01283 | |
| 0.036 | 0.126 | 0.076 | Porphobilinogen synthase inhibitor | 0.067 0.059 DBMET01275 0.076 0.05 DBMET01285 | DBMET01285 | |
| 0.011 | 0.102 | 0.022 | Retinoic acid receptor agonist | 0.022 0.018 DBMET01275 | DBMET01275 | |
| 0.058 | 0.151 | 0.107 | NADH dehydrogenase inhibitor | 0.107 0.037 DBMET01279 0.088 0.06 DBMET01275 0.098 0.046 DBMET01281 0.093 0.052 DBMET01276 0.084 0.067 DBMET01285 0.09 0.056 DBMET01283 0.089 0.058 DBMET01287 | DBMET01279 | |
| 0.155 | 0.248 | 0.448 | Immunosuppressant | 0.448 0.047 DBMET01279 0.439 0.05 DBMET01281 0.341 0.092 DBMET01283 | DBMET01279 | |
| 0.097 | 0.192 | 0.327 | Dual specificity phosphatase inhibitor | 0.13 0.12 DBMET01275 0.141 0.105 DBMET01285 0.136 0.112 DBMET01287 0.325 0.025 DBMET01286 0.327 0.024 DBMET01288 | DBMET01288 | |
| 0.021 | 0.116 | 0.083 | Nicotinic acid receptor 1 agonist | 0.053 0.019 DBMET01282 0.073 0.012 DBMET01276 0.083 0.01 DBMET01287 | DBMET01287 | |
| 0.008 | 0.104 | 0.028 | Kainate receptor 4 antagonist | 0.028 0.015 DBMET01276 | DBMET01276 | |
| 0.032 | 0.131 | 0.07 | Leukotriene synthesis inhibitor | 0.06 0.055 DBMET01274 0.07 0.044 DBMET01284 | DBMET01284 | |
| 0.039 | 0.138 | 0.097 | Phospholipase D inhibitor | 0.097 0.017 DBMET01276 0.074 0.046 DBMET01288 | DBMET01276 | |
| 0.143 | 0.245 | 0.196 | Neuropeptide Y2 antagonist | 0.196 0.126 DBMET01282 0.186 0.148 DBMET01276 | DBMET01282 | |
| 0.06 | 0.163 | 0.122 | MAP kinase 13 inhibitor | 0.115 0.061 DBMET01282 0.122 0.054 DBMET01276 | DBMET01276 | |
| 0.046 | 0.15 | 0.095 | Glycine receptor agonist | 0.069 0.056 DBMET01282 0.095 0.024 DBMET01276 0.082 0.036 DBMET01287 | DBMET01276 | |
| 0.025 | 0.135 | 0.046 | GABA B receptor antagonist | 0.046 0.025 DBMET01276 | DBMET01276 | |
| 0.02 | 0.133 | 0.054 | Glutamate (mGluR5) agonist | 0.054 0.022 DBMET01282 0.051 0.024 DBMET01276 | DBMET01282 | |
| 0.085 | 0.198 | 0.138 | Pyruvate kinase inhibitor | 0.138 0.126 DBMET01282 | DBMET01282 | |
| 0.061 | 0.174 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.071 DBMET01280 | DBMET01280 | |
| 0.089 | 0.203 | 0.158 | Amyloid beta precursor protein antagonist | 0.158 0.093 DBMET01276 0.152 0.1 DBMET01287 | DBMET01276 | |
| 0.12 | 0.235 | 0.512 | Hypoglycemic | 0.172 0.144 DBMET01274 0.368 0.034 DBMET01279 0.179 0.136 DBMET01280 0.233 0.087 DBMET01284 0.406 0.027 DBMET01281 0.211 0.103 DBMET01285 0.512 0.014 DBMET01283 0.166 0.153 DBMET01287 | DBMET01283 | |
| 0.015 | 0.132 | 0.095 | AMPA receptor antagonist | 0.095 0.013 DBMET01276 0.054 0.029 DBMET01287 | DBMET01276 | |
| 0.023 | 0.14 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.12 0.017 DBMET01286 0.1 0.023 DBMET01288 | DBMET01286 | |
| 0.026 | 0.145 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.031 DBMET01276 | DBMET01276 | |
| 0.027 | 0.148 | 0.09 | Androgen agonist | 0.09 0.019 DBMET01282 0.062 0.038 DBMET01287 | DBMET01282 | |
| 0.075 | 0.199 | 0.131 | Protein kinase stimulant | 0.131 0.082 DBMET01283 | DBMET01283 | |
| 0.098 | 0.224 | 0.184 | Platelet antagonist | 0.184 0.114 DBMET01279 0.163 0.132 DBMET01281 0.155 0.139 DBMET01283 | DBMET01279 | |
| 0.034 | 0.159 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | 0.078 0.019 DBMET01276 | DBMET01276 | |
| 0.01 | 0.138 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | 0.027 0.02 DBMET01287 | DBMET01287 | |
| 0.129 | 0.259 | 0.224 | RNA-directed DNA polymerase inhibitor | 0.202 0.096 DBMET01282 0.189 0.117 DBMET01276 0.167 0.158 DBMET01283 0.176 0.139 DBMET01287 0.224 0.069 DBMET01288 | DBMET01288 | |
| 0.023 | 0.154 | 0.275 | Selectin antagonist | 0.275 0.007 DBMET01279 0.274 0.007 DBMET01281 0.272 0.007 DBMET01283 0.159 0.016 DBMET01286 0.097 0.029 DBMET01288 | DBMET01279 | |
| 0.084 | 0.216 | 0.231 | NOS3 expression enhancer | 0.198 0.042 DBMET01279 0.191 0.045 DBMET01281 0.128 0.101 DBMET01276 0.231 0.031 DBMET01283 0.131 0.096 DBMET01287 | DBMET01283 | |
| 0.02 | 0.154 | 0.048 | 5 Hydroxytryptamine 2B agonist | 0.048 0.015 DBMET01282 | DBMET01282 | |
| 0.008 | 0.144 | 0.089 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 DBMET01279 0.039 0.009 DBMET01281 0.089 0.003 DBMET01283 | DBMET01283 | |
| 0.048 | 0.185 | 0.09 | Uric acid excretion stimulant | 0.09 0.065 DBMET01275 0.089 0.066 DBMET01285 0.082 0.08 DBMET01287 | DBMET01275 | |
| 0.026 | 0.165 | 0.135 | HIV-1 integrase (3'-Processing) inhibitor | 0.135 0.016 DBMET01286 0.116 0.021 DBMET01288 | DBMET01286 | |
| 0.088 | 0.228 | 0.15 | Melanin inhibitor | 0.128 0.118 DBMET01281 0.15 0.082 DBMET01283 | DBMET01283 | |
| 0.005 | 0.145 | 0.281 | Cholecystokinin B antagonist | 0.185 0.004 DBMET01286 0.281 0.004 DBMET01288 | DBMET01288 | |
| 0.093 | 0.234 | 0.19 | Antipruritic | 0.178 0.066 DBMET01282 0.144 0.101 DBMET01276 0.19 0.056 DBMET01287 | DBMET01287 | |
| 0.069 | 0.213 | 0.299 | Protein-tyrosine phosphatase inhibitor | 0.146 0.082 DBMET01275 0.153 0.076 DBMET01285 0.299 0.019 DBMET01286 0.259 0.029 DBMET01288 | DBMET01286 | |
| 0.014 | 0.163 | 0.086 | Carbonic anhydrase inhibitor | 0.086 0.032 DBMET01286 | DBMET01286 | |
| 0.007 | 0.156 | 0.321 | Cholecystokinin antagonist | 0.203 0.005 DBMET01286 0.321 0.004 DBMET01288 | DBMET01288 | |
| 0.009 | 0.159 | 0.104 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 DBMET01279 0.036 0.008 DBMET01281 0.025 0.019 DBMET01282 0.104 0.003 DBMET01283 | DBMET01283 | |
| 0.049 | 0.201 | 0.147 | Glutamate receptor antagonist | 0.124 0.07 DBMET01282 0.147 0.053 DBMET01276 0.147 0.053 DBMET01287 0.114 0.08 DBMET01288 | DBMET01287 | |
| 0.06 | 0.215 | 0.127 | Glutamate (mGluR7) agonist | 0.099 0.062 DBMET01282 0.127 0.024 DBMET01276 0.095 0.071 DBMET01287 | DBMET01276 | |
| 0.083 | 0.239 | 0.346 | Anticonvulsant | 0.207 0.078 DBMET01282 0.346 0.03 DBMET01276 0.184 0.095 DBMET01287 0.165 0.112 DBMET01288 | DBMET01276 | |
| 0.014 | 0.172 | 0.108 | RNA-directed RNA polymerase inhibitor | 0.035 0.023 DBMET01282 0.094 0.005 DBMET01276 0.108 0.005 DBMET01287 | DBMET01287 | |
| 0.087 | 0.248 | 0.413 | Immunostimulant | 0.408 0.047 DBMET01279 0.154 0.151 DBMET01284 0.413 0.046 DBMET01281 0.212 0.113 DBMET01283 0.165 0.143 DBMET01286 | DBMET01281 | |
| 0.035 | 0.199 | 0.18 | Protein-tyrosine phosphatase 1B inhibitor | 0.092 0.087 DBMET01275 0.101 0.077 DBMET01285 0.18 0.035 DBMET01286 0.124 0.06 DBMET01288 | DBMET01286 | |
| 0.025 | 0.191 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.036 DBMET01287 | DBMET01287 | |
| 0.009 | 0.175 | 0.051 | Factor XI inhibitor | 0.046 0.012 DBMET01286 0.051 0.01 DBMET01288 | DBMET01288 | |
| 0.101 | 0.272 | 0.169 | Cyclic AMP phosphodiesterase inhibitor | 0.169 0.123 DBMET01283 | DBMET01283 | |
| 0.011 | 0.183 | 0.029 | Purinergic P2Y14 antagonist | 0.029 0.023 DBMET01276 | DBMET01276 | |
| 0.01 | 0.182 | 0.108 | NMDA 2D receptor antagonist | 0.038 0.011 DBMET01276 0.031 0.015 DBMET01287 0.08 0.004 DBMET01286 0.108 0.004 DBMET01288 | DBMET01288 | |
| 0.005 | 0.178 | 0.338 | Cholecystokinin A antagonist | 0.235 0.004 DBMET01286 0.338 0.004 DBMET01288 | DBMET01288 | |
| 0.016 | 0.192 | 0.057 | Cyclin B2 inhibitor | 0.057 0.037 DBMET01282 | DBMET01282 | |
| 0.066 | 0.246 | 0.45 | Diuretic | 0.129 0.096 DBMET01276 0.164 0.065 DBMET01283 0.323 0.019 DBMET01286 0.45 0.01 DBMET01288 | DBMET01288 | |
| 0.059 | 0.243 | 0.124 | Mcl-1 antagonist | 0.124 0.12 DBMET01287 | DBMET01287 | |
| 0.085 | 0.272 | 0.365 | Tumour necrosis factor alpha release inhibitor | 0.365 0.034 DBMET01279 0.33 0.043 DBMET01281 0.215 0.096 DBMET01283 | DBMET01279 | |
| 0.026 | 0.218 | 0.171 | Androgen antagonist | 0.171 0.018 DBMET01282 0.108 0.041 DBMET01287 | DBMET01282 | |
| 0.162 | 0.355 | 0.292 | Calcium channel L-type activator | 0.292 0.164 DBMET01284 | DBMET01284 | |
| 0.016 | 0.21 | 0.049 | Alcohol oxidase inhibitor | 0.049 0.046 DBMET01285 | DBMET01285 | |
| 0.027 | 0.222 | 0.139 | Monophenol monooxygenase inhibitor | 0.111 0.068 DBMET01279 0.139 0.051 DBMET01281 | DBMET01281 | |
| 0.004 | 0.199 | 0.044 | Estrogen receptor alpha agonist | 0.044 0.019 DBMET01282 | DBMET01282 | |
| 0.019 | 0.217 | 0.059 | Cyclin B1 inhibitor | 0.059 0.045 DBMET01282 | DBMET01282 | |
| 0.009 | 0.208 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 DBMET01285 0.039 0.021 DBMET01287 | DBMET01287 | |
| 0.074 | 0.274 | 0.176 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.162 0.129 DBMET01282 0.176 0.116 DBMET01276 | DBMET01276 | |
| 0.014 | 0.215 | 0.057 | Nerve growth factor antagonist | 0.057 0.012 DBMET01276 0.039 0.038 DBMET01287 | DBMET01276 | |
| 0.023 | 0.224 | 0.039 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET01276 0.039 0.031 DBMET01287 | DBMET01287 | |
| 0.082 | 0.287 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.091 DBMET01275 0.149 0.074 DBMET01276 0.131 0.114 DBMET01285 0.139 0.095 DBMET01287 | DBMET01276 | |
| 0.015 | 0.222 | 0.1 | Glutamate (mGluR) agonist | 0.06 0.045 DBMET01282 0.1 0.023 DBMET01276 0.078 0.031 DBMET01287 | DBMET01276 | |
| 0.025 | 0.234 | 0.064 | Parathyroid hormone antagonist | 0.064 0.009 DBMET01282 0.058 0.012 DBMET01276 0.043 0.037 DBMET01283 0.05 0.022 DBMET01287 | DBMET01282 | |
| 0.028 | 0.238 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.054 DBMET01282 | DBMET01282 | |
| 0.015 | 0.226 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 DBMET01279 0.026 0.019 DBMET01281 0.026 0.019 DBMET01283 | DBMET01279 | |
| 0.038 | 0.25 | 0.148 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 DBMET01279 0.142 0.032 DBMET01281 0.1 0.061 DBMET01276 0.087 0.078 DBMET01285 0.148 0.029 DBMET01283 0.127 0.039 DBMET01287 | DBMET01283 | |
| 0.04 | 0.254 | 0.094 | Estrogen receptor alpha antagonist | 0.094 0.031 DBMET01282 0.075 0.057 DBMET01287 | DBMET01282 | |
| 0.019 | 0.234 | 0.058 | Nitric oxide donor | 0.058 0.052 DBMET01279 | DBMET01279 | |
| 0.005 | 0.219 | 0.082 | HCV NS5B polymerase inhibitor | 0.064 0.008 DBMET01276 0.082 0.006 DBMET01287 | DBMET01287 | |
| 0.016 | 0.232 | 0.044 | Acid-sensing ion channel blocker | 0.043 0.024 DBMET01282 0.043 0.024 DBMET01276 0.044 0.022 DBMET01287 | DBMET01287 | |
| 0.015 | 0.233 | 0.049 | Cyclin B inhibitor | 0.049 0.047 DBMET01282 | DBMET01282 | |
| 0.103 | 0.324 | 0.45 | Alpha-glucosidase inhibitor | 0.45 0.096 DBMET01279 0.416 0.108 DBMET01281 0.376 0.125 DBMET01283 | DBMET01279 | |
| 0.019 | 0.241 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.024 DBMET01282 0.05 0.024 DBMET01276 0.047 0.029 DBMET01287 | DBMET01282 | |
| 0.005 | 0.227 | 0.382 | Cholecystokinin A agonist | 0.288 0.002 DBMET01286 0.382 0.002 DBMET01288 | DBMET01288 | |
| 0.034 | 0.26 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 DBMET01279 0.101 0.039 DBMET01283 | DBMET01283 | |
| 0.016 | 0.247 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.08 0.02 DBMET01279 0.076 0.021 DBMET01281 0.094 0.015 DBMET01283 | DBMET01283 | |
| 0.097 | 0.332 | 0.386 | DNA synthesis inhibitor | 0.192 0.135 DBMET01279 0.203 0.118 DBMET01281 0.232 0.081 DBMET01282 0.287 0.048 DBMET01276 0.386 0.023 DBMET01283 0.314 0.039 DBMET01287 0.202 0.12 DBMET01288 | DBMET01283 | |
| 0.014 | 0.251 | 0.581 | Cholecystokinin B agonist | 0.512 0.002 DBMET01286 0.581 0.002 DBMET01288 | DBMET01288 | |
| 0.004 | 0.242 | 0.586 | Cholecystokinin agonist | 0.38 0.002 DBMET01286 0.586 0.002 DBMET01288 | DBMET01288 | |
| 0.109 | 0.347 | 0.423 | Antiobesity | 0.231 0.175 DBMET01282 0.261 0.147 DBMET01276 0.319 0.104 DBMET01283 0.265 0.143 DBMET01287 0.296 0.119 DBMET01286 0.423 0.057 DBMET01288 | DBMET01288 | |
| 0.004 | 0.243 | 0.027 | Estrogen receptor beta agonist | 0.027 0.024 DBMET01288 | DBMET01288 | |
| 0.034 | 0.276 | 0.055 | Lipocortins synthesis agonist | 0.054 0.052 DBMET01279 0.055 0.049 DBMET01283 | DBMET01283 | |
| 0.022 | 0.265 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.048 DBMET01282 | DBMET01282 | |
| 0.016 | 0.261 | 0.092 | 5 Hydroxytryptamine 2A agonist | 0.092 0.018 DBMET01282 | DBMET01282 | |
| 0.013 | 0.26 | 0.05 | GABA receptor antagonist | 0.05 0.045 DBMET01282 | DBMET01282 | |
| 0.116 | 0.368 | 0.337 | Apoptosis antagonist | 0.337 0.062 DBMET01279 0.33 0.066 DBMET01281 0.336 0.063 DBMET01283 | DBMET01279 | |
| 0.009 | 0.27 | 0.067 | Factor XIa inhibitor | 0.046 0.022 DBMET01276 0.045 0.023 DBMET01286 0.067 0.01 DBMET01288 | DBMET01288 | |
| 0.006 | 0.271 | 0.08 | Estrogen agonist | 0.065 0.028 DBMET01286 0.08 0.023 DBMET01288 | DBMET01288 | |
| 0.013 | 0.279 | 0.048 | GABA A receptor antagonist | 0.048 0.045 DBMET01282 | DBMET01282 | |
| 0.004 | 0.276 | 0.063 | Estrone sulfatase inhibitor | 0.063 0.006 DBMET01286 0.058 0.006 DBMET01288 | DBMET01286 | |
| 0.111 | 0.384 | 0.233 | GABA C receptor rho-3 antagonist | 0.233 0.17 DBMET01282 | DBMET01282 | |
| 0.045 | 0.321 | 0.13 | Estrogen antagonist | 0.12 0.056 DBMET01280 0.113 0.069 DBMET01284 0.13 0.038 DBMET01282 0.113 0.068 DBMET01285 0.122 0.052 DBMET01287 | DBMET01282 | |
| 0.059 | 0.337 | 0.298 | Platelet adhesion inhibitor | 0.266 0.044 DBMET01279 0.286 0.038 DBMET01281 0.298 0.035 DBMET01283 0.236 0.054 DBMET01286 0.212 0.065 DBMET01288 | DBMET01283 | |
| 0.106 | 0.385 | 0.317 | Peptidyltransferase inhibitor | 0.301 0.024 DBMET01279 0.299 0.025 DBMET01281 0.317 0.019 DBMET01283 | DBMET01283 | |
| 0.061 | 0.341 | 0.294 | Hepatoprotectant | 0.283 0.035 DBMET01279 0.293 0.032 DBMET01281 0.294 0.031 DBMET01283 0.134 0.128 DBMET01286 | DBMET01283 | |
| 0.008 | 0.299 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.027 DBMET01287 | DBMET01287 | |
| 0.078 | 0.369 | 0.169 | Superoxide dismutase inhibitor | 0.169 0.157 DBMET01286 | DBMET01286 | |
| 0.063 | 0.362 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | 0.137 0.125 DBMET01276 | DBMET01276 | |
| 0.046 | 0.347 | 0.13 | MAP3K9 inhibitor | 0.13 0.095 DBMET01274 0.128 0.098 DBMET01284 | DBMET01274 | |
| 0.015 | 0.318 | 0.141 | DNA gyrase inhibitor | 0.072 0.034 DBMET01282 0.141 0.009 DBMET01276 0.095 0.02 DBMET01283 0.115 0.014 DBMET01287 | DBMET01276 | |
| 0.017 | 0.323 | 0.062 | DNA gyrase subunit A inhibitor | 0.053 0.014 DBMET01282 0.062 0.009 DBMET01276 0.042 0.03 DBMET01283 0.061 0.01 DBMET01287 | DBMET01276 | |
| 0.051 | 0.358 | 0.272 | Nitric oxide antagonist | 0.254 0.051 DBMET01279 0.272 0.046 DBMET01281 0.249 0.052 DBMET01283 | DBMET01281 | |
| 0.019 | 0.327 | 0.14 | Cyclin B3 inhibitor | 0.139 0.016 DBMET01282 0.14 0.016 DBMET01276 0.125 0.02 DBMET01287 | DBMET01276 | |
| 0.005 | 0.314 | 0.08 | Glutamate (mGluR1) antagonist | 0.08 0.023 DBMET01276 | DBMET01276 | |
| 0.088 | 0.398 | 0.326 | Immunomodulator | 0.326 0.069 DBMET01279 0.314 0.075 DBMET01281 0.28 0.094 DBMET01283 | DBMET01279 | |
| 0.034 | 0.347 | 0.221 | Lipid peroxidase inhibitor | 0.201 0.041 DBMET01279 0.221 0.034 DBMET01281 0.156 0.064 DBMET01283 | DBMET01281 | |
| 0.032 | 0.346 | 0.215 | Thrombolytic | 0.167 0.069 DBMET01279 0.181 0.062 DBMET01281 0.215 0.045 DBMET01283 0.157 0.076 DBMET01286 0.156 0.078 DBMET01288 | DBMET01283 | |
| 0.005 | 0.331 | 0.069 | 5 Hydroxytryptamine 2 agonist | 0.069 0.02 DBMET01282 | DBMET01282 | |
| 0.038 | 0.365 | 0.382 | Anticoagulant | 0.124 0.107 DBMET01279 0.125 0.106 DBMET01281 0.164 0.069 DBMET01283 0.369 0.019 DBMET01286 0.382 0.018 DBMET01288 | DBMET01288 | |
| 0.035 | 0.368 | 0.095 | DNA polymerase I inhibitor | 0.095 0.091 DBMET01281 | DBMET01281 | |
| 0.021 | 0.372 | 0.099 | Alkylator | 0.099 0.089 DBMET01281 | DBMET01281 | |
| 0.015 | 0.367 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.059 0.033 DBMET01282 | DBMET01282 | |
| 0.014 | 0.367 | 0.05 | Phosphodiesterase 7A inhibitor | 0.05 0.04 DBMET01276 | DBMET01276 | |
| 0.027 | 0.387 | 0.116 | Estrogen receptor beta antagonist | 0.1 0.064 DBMET01280 0.092 0.08 DBMET01284 0.116 0.037 DBMET01282 0.094 0.076 DBMET01285 0.108 0.05 DBMET01287 | DBMET01282 | |
| 0.028 | 0.396 | 0.126 | Nav1.6 sodium channel blocker | 0.126 0.087 DBMET01282 | DBMET01282 | |
| 0.038 | 0.407 | 0.129 | Heat shock protein 90 alpha antagonist | 0.129 0.113 DBMET01282 | DBMET01282 | |
| 0.034 | 0.404 | 0.527 | Angiogenesis stimulant | 0.417 0.019 DBMET01279 0.427 0.018 DBMET01281 0.527 0.01 DBMET01283 0.312 0.045 DBMET01286 0.352 0.032 DBMET01288 | DBMET01283 | |
| 0.005 | 0.376 | 0.08 | Factor Xa inhibitor | 0.08 0.018 DBMET01288 | DBMET01288 | |
| 0.014 | 0.392 | 0.063 | Dopamine D1 antagonist | 0.063 0.047 DBMET01282 | DBMET01282 | |
| 0.047 | 0.43 | 0.434 | Antioxidant | 0.391 0.036 DBMET01279 0.434 0.029 DBMET01281 0.398 0.035 DBMET01283 0.17 0.142 DBMET01286 0.162 0.151 DBMET01288 | DBMET01281 | |
| 0.039 | 0.433 | 0.387 | Free radical scavenger | 0.346 0.04 DBMET01279 0.387 0.031 DBMET01281 0.371 0.034 DBMET01283 | DBMET01281 | |
| 0.005 | 0.4 | 0.107 | Antineoplastic antibiotic | 0.091 0.05 DBMET01279 0.096 0.048 DBMET01281 0.107 0.043 DBMET01283 | DBMET01283 | |
| 0.06 | 0.457 | 0.173 | Histone acetyltransferase inhibitor | 0.167 0.117 DBMET01282 0.173 0.11 DBMET01276 0.158 0.128 DBMET01287 | DBMET01276 | |
| 0.011 | 0.417 | 0.078 | Neuraminidase (influenza) inhibitor | 0.067 0.04 DBMET01286 0.078 0.026 DBMET01288 | DBMET01288 | |
| 0.008 | 0.424 | 0.065 | Nav1.7 sodium channel blocker | 0.065 0.05 DBMET01282 | DBMET01282 | |
| 0.014 | 0.432 | 0.071 | Thrombin inhibitor | 0.071 0.053 DBMET01286 0.067 0.059 DBMET01288 | DBMET01286 | |
| 0.03 | 0.459 | 0.151 | Heat shock protein 90 antagonist | 0.151 0.074 DBMET01282 | DBMET01282 | |
| 0.018 | 0.447 | 0.164 | Sodium channel (voltage-gated) blocker | 0.164 0.045 DBMET01282 0.109 0.098 DBMET01276 0.107 0.101 DBMET01287 | DBMET01282 | |
| 0.007 | 0.437 | 0.097 | Benzodiazepine agonist | 0.072 0.049 DBMET01282 0.097 0.027 DBMET01276 | DBMET01276 | |
| 0.029 | 0.471 | 0.27 | Cell wall synthesis inhibitor | 0.149 0.066 DBMET01276 0.223 0.022 DBMET01283 0.14 0.075 DBMET01287 0.145 0.07 DBMET01286 0.27 0.013 DBMET01288 | DBMET01288 | |
| 0.062 | 0.507 | 0.651 | Antibacterial | 0.541 0.03 DBMET01279 0.555 0.027 DBMET01281 0.311 0.127 DBMET01282 0.395 0.079 DBMET01276 0.651 0.013 DBMET01283 0.434 0.062 DBMET01287 0.285 0.147 DBMET01286 0.539 0.031 DBMET01288 | DBMET01283 | |
| 0.007 | 0.453 | 0.058 | Neuraminidase inhibitor | 0.058 0.045 DBMET01288 | DBMET01288 | |
| 0.007 | 0.459 | 0.1 | Acetylcholine M5 receptor agonist | 0.1 0.02 DBMET01282 0.091 0.026 DBMET01276 | DBMET01282 | |
| 0.011 | 0.472 | 0.048 | DNA topoisomerase IV inhibitor | 0.035 0.012 DBMET01282 0.048 0.006 DBMET01276 0.031 0.018 DBMET01283 0.041 0.008 DBMET01287 0.028 0.026 DBMET01288 | DBMET01276 | |
| 0.031 | 0.493 | 0.09 | Phosphodiesterase 6D inhibitor | 0.09 0.076 DBMET01283 | DBMET01283 | |
| 0.044 | 0.506 | 0.131 | DNA repair enzyme inhibitor | 0.131 0.054 DBMET01283 | DBMET01283 | |
| 0.009 | 0.477 | 0.06 | Elastase inhibitor | 0.052 0.038 DBMET01286 0.06 0.03 DBMET01288 | DBMET01288 | |
| 0.027 | 0.501 | 0.097 | Acetylcholine release stimulant | 0.097 0.094 DBMET01288 | DBMET01288 | |
| 0.014 | 0.493 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET01283 | DBMET01283 | |
| 0.059 | 0.545 | 0.197 | Vasodilator, peripheral | 0.197 0.18 DBMET01276 | DBMET01276 | |
| 0.004 | 0.492 | 0.091 | Nociceptin (N/OFQ) receptor antagonist | 0.091 0.006 DBMET01282 0.071 0.009 DBMET01276 0.056 0.012 DBMET01287 | DBMET01282 | |
| 0.005 | 0.506 | 0.176 | NMDA 2B receptor antagonist | 0.073 0.024 DBMET01286 0.176 0.007 DBMET01288 | DBMET01288 | |
| 0.014 | 0.517 | 0.143 | Sodium channel blocker | 0.143 0.063 DBMET01282 | DBMET01282 | |
| 0.005 | 0.517 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET01279 0.024 0.017 DBMET01281 0.027 0.014 DBMET01283 | DBMET01283 | |
| 0.011 | 0.565 | 0.225 | Topoisomerase II inhibitor | 0.126 0.062 DBMET01282 0.152 0.048 DBMET01276 0.225 0.028 DBMET01283 0.174 0.04 DBMET01287 0.1 0.086 DBMET01288 | DBMET01283 | |
| 0.01 | 0.596 | 0.057 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET01279 0.05 0.014 DBMET01281 0.057 0.01 DBMET01283 | DBMET01283 | |
| 0.046 | 0.66 | 0.46 | Apoptosis agonist | 0.454 0.09 DBMET01279 0.46 0.087 DBMET01281 0.405 0.111 DBMET01283 | DBMET01281 | |
| 0.003 | 0.626 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET01286 0.029 0.017 DBMET01288 | DBMET01288 | |
| 0.006 | 0.708 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.024 DBMET01276 0.033 0.023 DBMET01287 | DBMET01287 | |
| 0.004 | 0.731 | 0.062 | Dopamine agonist | 0.062 0.051 DBMET01282 | DBMET01282 | |
| 0.006 | 0.734 | 0.118 | Topoisomerase I inhibitor | 0.118 0.056 DBMET01283 | DBMET01283 | |
| 0.009 | 0.741 | 0.11 | DNA intercalator | 0.11 0.065 DBMET01283 | DBMET01283 | |
| 0.003 | 0.825 | 0.039 | Dopamine D2 agonist | 0.039 0.035 DBMET01288 | DBMET01288 | |
| 0.008 | 0.835 | 0.187 | Vasodilator | 0.187 0.115 DBMET01283 | DBMET01283 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |